Case Based Pediatrics For Medical Students and Residents
Department of Pediatrics, University of Hawaii John A. Burns School of Medicine
Index

Return to Table of Contents

17-OH progesterone : Chapter XV.4
21-hydroxylase deficiency : Chapter XIII.11
21-hydroxylase deficiency : Chapter XV.4
abdominal abscess : Chapter X.11
abdominal pain : Chapter IX.2
abdominal pain : Chapter X.3
abducens nerve (CN VI) : Chapter XVIII.1
ABO incompatibility : Chapter III.2
ABO isoimmunization : Chapter III.2
abrasions : Chapter X.1
abruptio placentae : Chapter III.3
abscess : Chapter VI.2
abscess : Chapter VI.13
abscess : Chapter VI.34
abscess : Chapter X.11
absence seizure : Chapter XVIII.4
absence status epilepticus : Chapter XVIII.5
absolute risk reduction : Chapter XXII.2
accommodation reflex : Chapter XVIII.1
ACE inhibitors : Chapter VII.1
acetaminophen : Chapter VI.3
acetaminophen : Chapter XIV.9
acetaminophen overdose : Chapter XIV.10
Achilles reflex : Chapter XVIII.1
Achilles tendonitis : Chapter XIX.8
achondroplasia : Chapter I.2
achondroplasia : Chapter IV.1
achondroplasia : Chapter IV.2
acidosis : Chapter VIII.1
acidosis : Chapter XIV.1
acidosis : Chapter XIV.3
acidosis : Chapter XIV.9
acne : Chapter XXI.2
acoustic neuroma : Chapter XVIII.11
acrocyanosis : Chapter III.7
acromioclavicular injury : Chapter XIX.7
ACTH : Chapter XV.4
ACTH : Chapter XVIII.12
activated charcoal : Chapter XIV.9
activated charcoal : Chapter XIV.10
active immunization : Chapter I.4
acute chest syndrome : Chapter XI.3
acute endocarditis : Chapter VII.5
acute glomerulonephritis : Chapter XIII.1
acute lymphoblastic leukemia : Chapter XII.2
acute lymphocytic leukemia : Chapter XII.2
acute osteomyelitis : Chapter XIX.4
acute otitis media (AOM) : Chapter VI.6
acute respiratory infection (ARI) : Chapter VI.11
acute retroviral syndrome : Chapter VI.20
acute rheumatic fever : Chapter VII.4
acute scrotum : Chapter XIII.10
acyanotic congenital heart disease : Chapter VII.2
acyclovir : Chapter VI.15
acyclovir : Chapter VI.21
acyclovir : Chapter XXI.6
ADD : Chapter I.8
ADD : Chapter I.10
addiction : Chapter XX.3
Addisonian crisis : Chapter XIII.11
Addison's disease : Chapter XV.4
adenoma sebaceum : Chapter XVIII.1
adenoma sebaceum : Chapter XVIII.12
adenosine deaminase deficiency : Chapter V.5
adenovirus : Chapter VI.1
adenovirus : Chapter VI.9
adenovirus : Chapter VI.10
adenovirus : Chapter VI.22
ADH : Chapter XV.5
ADHD : Chapter I.8
ADHD : Chapter I.10
ADHD : Chapter XV.3
adjusted mid-parental height : Chapter XV.3
adolescent gynecology : Chapter XX.7
adrenal insufficiency : Chapter XV.4
adrenal cortex : Chapter V.4
adrenal insufficiency : Chapter III.8
adrenarche : Chapter XX.1
African sleeping sickness : Chapter VI.31
afterload : Chapter XIV.2
aganglionosis : Chapter IX.9
AIDS : Chapter VI.20
air contrast enema : Chapter X.4
airway : Chapter VIII.10
airway : Chapter XIV.4
airway : Chapter XIV.8
alanine aminotransferase (ALT) : Chapter IX.5
albendazole : Chapter VI.31
albumin : Chapter XIV.2
albuminocytologic dissociation : Chapter XVIII.7
albuterol : Chapter V.2
albuterol : Chapter VIII.2
albuterol : Chapter VIII.4
albuterol : Chapter XIV.2
albuterol : Chapter XV.4
alcohol : Chapter XIV.9
alcoholism : Chapter XX.3
aldosterone : Chapter V.4
alkaline phosphatase : Chapter IX.5
alkalosis : Chapter VIII.1
alkylating agents : Chapter XII.1
ALL : Chapter XII.2
allergic bronchopulmonary aspergillosis : Chapter VIII.3
allergic conjunctivitis : Chapter V.1
allergic dermatitis : Chapter XXI.6
allergic enteropathy : Chapter IX.10
allergic reaction : Chapter V.2
allergic rhinitis : Chapter V.1
allergic rhinitis : Chapter XXI.1
allergic shiner : Chapter V.1
allergy : Chapter V.1
allergy : Chapter V.2
allergy immunotherapy : Chapter V.1
allergy prevention : Chapter V.1
allogeneic transplant : Chapter V.6
alopecia : Chapter XVI.1
alpha fetoprotein : Chapter IV.1
alpha fetoprotein : Chapter XVIII.10
alpha globin : Chapter XI.2
alpha hemolytic strep : Chapter VI.2
alpha thal trait : Chapter XI.2
alpha thalassemia : Chapter XI.2
alpha-1-antitrypsin deficiency : Chapter IX.4
alpha-1-antitrypsin deficiency : Chapter IX.5
Alport's disease : Chapter XIII.1
ALTE : Chapter VIII.12
ALTE : Chapter IX.6
alternate cover test : Chapter XVII.3
amanita : Chapter XIV.9
ambiguous genitalia : Chapter XIII.11
amblyopia : Chapter XVII.2
amblyopia : Chapter XVII.3
ameba : Chapter VI.31
amebiasis : Chapter VI.31
amebiasis : Chapter IX.3
amebic abscess : Chapter X.11
amebic dysentery : Chapter IX.3
amebic liver abscess : Chapter IX.3
amelogenesis imperfecta : Chapter I.12
amenorrhea : Chapter XX.5
amenorrhea : Chapter XX.7
American trypanosomiasis : Chapter VI.31
Americans with Disabilities Act : Chapter I.8
amikacin : Chapter VI.5
aminocaproic acid : Chapter XI.6
aminoglycosides : Chapter VI.5
aminoglycosides : Chapter XVIII.6
aminophylline : Chapter VIII.2
amitriptyline : Chapter XIV.9
amniocentesis : Chapter IV.1
amniotic band syndrome : Chapter IV.2
amoxicillin : Chapter VI.5
amoxicillin : Chapter VI.10
amoxicillin/ampicillin rash : Chapter VI.22
amphetamine : Chapter XX.3
amphetamines : Chapter XIV.9
ampicillin : Chapter VI.5
ampicillin prophylaxis : Chapter III.10
ANA : Chapter XVI.1
anabolic steroids : Chapter XX.2
anaerobes : Chapter VI.2
anaerobes : Chapter X.11
anal fissure : Chapter IX.10
analgesia : Chapter XII.4
analgesics : Chapter XIV.4
analgesics : Chapter XIV.9
analysis of variance : Chapter XXII.1
anaphase lag : Chapter IV.7
anaphylactic shock : Chapter V.2
anaphylactoid purpura : Chapter IX.10
anaphylactoid reaction : Chapter V.2
anaphylaxis : Chapter V.2
anaphylaxis : Chapter V.3
anaphylaxis : Chapter XXI.5
ANCA : Chapter IX.11
Ancylostoma duodenale : Chapter VI.31
androgens : Chapter XXI.2
androstenedione : Chapter XV.4
anemia : Chapter III.5
anemia : Chapter XI.1
anemia : Chapter XI.3
anemia : Chapter XI.4
anemia : Chapter XII.4
anemia : Chapter XIII.5
anemia : Chapter XVI.1
anencephaly : Chapter IV.2
anencephaly : Chapter XVIII.10
anergy : Chapter V.5
anergy : Chapter VI.20
aneuploidy : Chapter IV.1
aneuploidy : Chapter IV.7
anger : Chapter XX.4
angioedema : Chapter V.2
angioedema : Chapter V.3
angiofibroma : Chapter XVIII.12
angiokeratoma circumscriptum : Chapter X.12
angioma : Chapter XVIII.19
angiomas : Chapter XVIII.1
angulation : Chapter XIX.1
anicteric leptospirosis : Chapter VI.28
animal bites : Chapter VI.13
animal bites : Chapter X.1
anion gap : Chapter II.4
anion gap : Chapter XIV.9
ankle posterior splint : Chapter XIX.2
ankle reflex : Chapter XVIII.1
ankle sprain : Chapter XIX.7
ankylosing spondylitis : Chapter XVI.2
anopheles mosquito : Chapter VI.30
ano-rectal manometry : Chapter IX.9
anorexia : Chapter XII.4
anorexia nervosa : Chapter XX.5
antacids : Chapter IX.6
anterior cruciate ligament injury : Chapter XIX.7
anthropometrics : Chapter II.1
anti-A : Chapter XI.7
antiangiogenesis agents : Chapter XII.1
anti-B : Chapter XI.7
anti-beta-lactamase : Chapter VI.2
antibiotic prophylaxis : Chapter VI.5
antibiotics : Chapter III.10
antibiotics : Chapter VI.5
anticholinergics : Chapter XIV.9
anticipatory guidance : Chapter I.6
anticoagulant : Chapter XI.6
anticoagulant : Chapter XVI.1
anticonvulsants : Chapter IV.2
anticonvulsants : Chapter XVIII.3
anticonvulsants : Chapter XVIII.4
antidepressants : Chapter I.10
antidepressants : Chapter XIV.9
antidiuretic hormone : Chapter XV.5
antidotes : Chapter XIV.9
anti-ds DNA : Chapter XVI.1
antiemetics : Chapter XII.1
antiemetics : Chapter XII.4
anti-endotoxin : Chapter XIV.2
anti-epileptic drugs (AED) : Chapter XVIII.4
anti-ganglioside antibody : Chapter XVIII.7
antigliadin antibodies : Chapter IX.12
antihistamine : Chapter V.1
antihistamines : Chapter V.2
antihistamines : Chapter XIV.9
antihistamines : Chapter XVII.4
antimalarials : Chapter XIV.9
anti-neutrophil cytoplasmic antibodies (ANCA) : Chapter IX.11
antinuclear antibody (ANA) : Chapter XVI.2
antiphospholipid antibody : Chapter XI.6
anti-retroviral therapy : Chapter VI.20
anti-Saccharomyces cerevisiae antibody (ASCA) : Chapter IX.11
anti-Sm : Chapter XVI.1
anti-staph penicillins : Chapter VI.5
anti-tissue transglutaminase : Chapter IX.12
anti-TNF-alpha : Chapter IX.11
aortic coarctation : Chapter VII.1
aortic coarctation : Chapter VII.2
aortic dissection : Chapter IV.5
aortic insufficiency : Chapter VII.2
aortic insufficiency : Chapter VII.4
aortic stenosis : Chapter VII.2
aortitis : Chapter VI.21
aortitis : Chapter VII.5
Apert's syndrome : Chapter X.10
aphasia : Chapter I.9
aphthoid lesions : Chapter IX.11
aplastic anemia : Chapter XI.1
aplastic anemia : Chapter XI.4
aplastic crisis : Chapter VI.1
aplastic crisis : Chapter XI.3
apnea : Chapter III.3
apnea : Chapter III.5
apnea : Chapter III.10
apnea : Chapter VI.10
apnea : Chapter VIII.10
apnea : Chapter VIII.12
apnea : Chapter IX.6
apophysitis : Chapter XIX.8
apparent life threatening event : Chapter VIII.12
appendiceal torsion : Chapter XIII.10
appendicitis : Chapter IX.2
appendicitis : Chapter X.3
appendicolith : Chapter X.3
appendix epididymis : Chapter XIII.10
appendix testis : Chapter XIII.10
Apt test : Chapter IX.10
aqueductal stenosis : Chapter XVIII.9
aqueous humor : Chapter XVII.2
arbovirus : Chapter VI.15
ARDS (adult respiratory distress syndrome) : Chapter VI.16
ARDS (adult respiratory distress syndrome) : Chapter XIV.3
arenavirus : Chapter VI.1
arginine vasopressin : Chapter XV.5
Argyll Robertson pupil : Chapter XVIII.1
Arnold-Chiari malformation : Chapter XVIII.10
Arnold-Chiari malformation : Chapter XVIII.16
arrhythmia : Chapter VII.6
arterial blood gas : Chapter VIII.1
arterial blood gas : Chapter XIV.3
arteriovenous malformation : Chapter XVIII.19
arthritis : Chapter VI.17
arthritis : Chapter VII.4
arthritis : Chapter XVI.1
arthritis : Chapter XVI.2
arthritis : Chapter XIX.5
arthrocentesis : Chapter XIX.5
arthropod bites/stings : Chapter XXI.5
arthropod vector : Chapter XXI.5
Ascaris lumbricoides : Chapter VI.31
ASD : Chapter VII.2
aseptic meningitis : Chapter VI.14
aseptic meningitis : Chapter VI.20
ash leaf spot : Chapter XVIII.1
ash leaf spot : Chapter XVIII.12
aspartate aminotransferase (AST) : Chapter IX.5
Asperger's disorder : Chapter I.9
aspergillosis : Chapter VIII.3
asphyxia : Chapter XIV.6
aspiration : Chapter VIII.5
aspiration : Chapter IX.6
aspiration pneumonia : Chapter VI.11
aspiration pneumonia : Chapter XVIII.2
aspirin : Chapter VI.17
asplenia : Chapter XI.3
asthma : Chapter VIII.2
asthma : Chapter XIV.3
asthma action plan : Chapter VIII.2
asthma management plan : Chapter VIII.2
astrocytoma : Chapter XVIII.12
astrocytoma : Chapter XVIII.18
astrovirus : Chapter IX.3
asystole : Chapter XIV.1
ataxia : Chapter VI.15
ataxia telangiectasia : Chapter V.5
ataxia telangiectasia : Chapter XVIII.11
ataxia telangiectasia : Chapter XVIII.12
atelectasis : Chapter VIII.6
atelectasis : Chapter XIV.3
atopic dermatitis : Chapter V.3
atopic dermatitis : Chapter XXI.1
atopic disease : Chapter VIII.2
atovaquone/proguanil : Chapter VI.30
atrial fibrillation : Chapter VII.6
atrial flutter : Chapter VII.6
atrial septal defect : Chapter VII.2
atropine : Chapter XIV.9
attention deficit disorder : Chapter I.8
attention deficit disorder : Chapter I.10
attention deficit/hyperactivity disorder : Chapter I.10
auditory brainstem response (ABR) : Chapter I.5
auditory nerve (CN VIII) : Chapter XVIII.1
autism : Chapter I.3
autism : Chapter I.8
autism : Chapter I.9
autistic disorder : Chapter I.9
autoimmune : Chapter XV.4
autoimmune thyroiditis : Chapter XV.2
autologous transplant : Chapter V.6
automated auditory brainstem response (AABR) : Chapter I.5
autosomal dominant : Chapter IV.4
autosomal dominant : Chapter IV.7
autosomal recessive : Chapter IV.4
autosomal recessive : Chapter IV.7
AV block : Chapter VII.6
AV fistula : Chapter XIII.4
AV graft : Chapter XIII.4
avascular necrosis, hip : Chapter XIX.6
AVM : Chapter XVIII.19
AVP : Chapter XV.5
axillary freckling : Chapter XVIII.1
axillary freckling : Chapter XVIII.11
axillary temperature : Chapter VI.3
azathioprine : Chapter IX.11
azathioprine : Chapter XVI.1
azithromycin : Chapter VI.5
azithromycin : Chapter VI.21
azithromycin : Chapter VI.29
azlocillin : Chapter VI.5
azoospermia : Chapter VIII.3
azotemia : Chapter XIII.1
azotemia : Chapter XIII.4
B12 deficiency : Chapter XI.1
Babinski's sign : Chapter XVIII.1
baby bottle (caries) syndrome : Chapter I.12
Bacillus : Chapter VI.2
Bacillus anthracis : Chapter VI.2
bacteremia : Chapter VI.2
bacteremia : Chapter VI.3
bacteremia : Chapter VI.16
bacterial conjunctivitis : Chapter XVII.4
bacterial endocarditis : Chapter VII.5
bacterial meningitis : Chapter VI.14
bacterial overgrowth : Chapter IX.12
bacterial vaginosis : Chapter VI.21
bactericidal : Chapter VI.4
bacteriocidal : Chapter VI.4
bacteriology : Chapter VI.5
bacteriostatic : Chapter VI.4
Bacteroides fragilis : Chapter VI.2
Bacteroides fragilis : Chapter VI.5
bag mask ventilation : Chapter XIV.1
balanced translocation : Chapter IV.7
barbiturate coma : Chapter XVIII.5
barbiturates : Chapter XIV.9
barbiturates : Chapter XX.3
barium enema : Chapter X.4
Barlow sign : Chapter XIX.6
barotrauma : Chapter III.5
barotrauma : Chapter XIV.3
Barr body : Chapter IV.7
Bartonella henselae : Chapter VI.29
base excess : Chapter VIII.1
basilar skull fracture : Chapter XVIII.13
Battle's sign : Chapter XVIII.13
Bayes theorem : Chapter XXII.2
BCG : Chapter VI.19
Becker muscular dystrophy : Chapter XVIII.14
Beckwith-Wiedemann syndrome : Chapter III.8
Beckwith-Wiedemann syndrome : Chapter XII.3
beclomethasone : Chapter VIII.2
behavior : Chapter I.7
bell clapper deformity : Chapter XIII.10
Bell's palsy : Chapter VI.27
benzodiazepines : Chapter XIV.9
benzodiazepines : Chapter XVIII.5
benzodiazepines : Chapter XX.3
benzoyl peroxide : Chapter XXI.2
Bernard-Soulier syndrome : Chapter XI.6
beta agonists : Chapter VIII.2
beta blockers : Chapter VII.1
beta globin : Chapter XI.2
beta globin chain : Chapter XI.3
beta hemolytic strep : Chapter VI.2
beta lactamase : Chapter VI.5
beta strep : Chapter VI.2
beta thalassemia major : Chapter XI.2
beta thalassemia minor : Chapter XI.2
beta-2 agonists : Chapter VIII.2
betacarotene : Chapter II.6
beta-lactamase : Chapter VI.2
bezoar : Chapter IX.7
Bezold abscess : Chapter VI.8
bicarbonate : Chapter VIII.1
bicarbonate : Chapter XV.4
biceps reflex : Chapter XVIII.1
bicuspid aortic valve : Chapter VII.2
biliary atresia : Chapter III.2
biliary atresia : Chapter IX.4
biliary colic : Chapter IX.2
bilirubin : Chapter III.2
binge eating : Chapter XX.5
biphasic anaphylaxis : Chapter V.2
biphasic reaction : Chapter VIII.2
bipolar depression : Chapter XX.4
birth asphyxia : Chapter III.8
birth control pills : Chapter XX.7
birth depression : Chapter III.10
bisexuality : Chapter XX.6
bites : Chapter XIV.9
BK virus : Chapter VI.1
Black Widow spider : Chapter XXI.5
blackhead : Chapter XXI.2
black-legged tick : Chapter VI.27
blackwater fever : Chapter VI.30
Blalock-Taussig shunt : Chapter VII.3
bleeding time : Chapter XI.6
blood brain barrier : Chapter VI.5
blood culture : Chapter III.10
blood gas : Chapter VIII.1
blood gas : Chapter XIV.3
blood gas, arterial : Chapter VIII.1
blood gas, capillary : Chapter VIII.1
blood gas, venous : Chapter VIII.1
blood transfusion : Chapter XIV.2
blood type : Chapter XI.7
Bloom syndrome : Chapter XVIII.11
blue dot sign : Chapter XIII.10
blueberry muffin rash : Chapter III.11
BMI : Chapter I.2
body image : Chapter XX.5
body mass index (BMI) : Chapter I.2
body mass index (BMI) : Chapter II.1
body surface area : Chapter XXI.4
bolus : Chapter II.4
bone age : Chapter XV.3
bone age : Chapter XX.1
bone marrow : Chapter XII.2
bone marrow failure : Chapter XI.4
bone marrow transplant : Chapter V.6
bone marrow transplantation : Chapter IV.6
bone marrow transplantation : Chapter XI.3
bone marrow transplantation : Chapter XII.1
bone scan : Chapter XIX.4
Bordetella pertussis : Chapter VI.10
Borrelia burgdorferi : Chapter VI.27
Boston exanthem : Chapter VI.22
botulinum immune globulin : Chapter XVIII.6
botulism : Chapter XIV.3
botulism : Chapter XVIII.6
bowel infarction : Chapter IX.2
bowel infarction : Chapter X.5
bowel ischemia : Chapter III.12
bowel obstruction : Chapter IX.2
bowel obstruction : Chapter X.4
bowel obstruction : Chapter X.5
bowing fracture : Chapter XIX.1
box jellyfish : Chapter XXI.5
BPD : Chapter VIII.4
brachioradialis reflex : Chapter XVIII.1
bradycardia : Chapter VII.6
bradycardia : Chapter XIV.1
brain abscess : Chapter X.11
brain injury : Chapter XVIII.13
brain malformation : Chapter XVIII.16
brain tumor : Chapter XVIII.18
brainstem auditory evoked response (BAER) : Chapter I.5
brainstem auditory evoked response : Chapter XVIII.8
breast feeding : Chapter II.1
breast feeding : Chapter II.3
breast feeding : Chapter III.1
breast milk : Chapter II.2
breastfeeding : Chapter II.2
breastfeeding : Chapter III.11
breastfeeding : Chapter VI.20
bronchial foreign body : Chapter VIII.6
bronchial inflammation : Chapter VIII.2
bronchial stenosis : Chapter VIII.6
bronchiectasis : Chapter VIII.3
bronchiectasis : Chapter VIII.5
bronchiectasis : Chapter VIII.6
bronchiolitis : Chapter VI.11
bronchiolitis : Chapter XIV.3
bronchitis : Chapter VI.11
bronchoalveolar lavage : Chapter VIII.7
bronchodilators : Chapter VIII.4
bronchogenic cyst : Chapter VIII.9
bronchography : Chapter VIII.5
bronchopulmonary dysplasia : Chapter III.6
bronchopulmonary dysplasia : Chapter VIII.1
bronchopulmonary dysplasia : Chapter VIII.4
bronchopulmonary dysplasia : Chapter XIV.3
bronchoscopy : Chapter VIII.6
bronchoscopy : Chapter VIII.10
bronchospasm : Chapter V.2
bronchospasm : Chapter VIII.2
bronchospasm : Chapter VIII.3
bronchospasm : Chapter VIII.4
bronchospastic phase : Chapter VIII.2
Bronstein : Chapter XIII.8
bronzing : Chapter XV.4
Broselow tape : Chapter XIV.1
brown recluse spider : Chapter XXI.5
brown violin spider : Chapter XXI.5
Brugia malayi : Chapter VI.31
Bruton's agammaglobulinemia : Chapter XXI.1
budesonide : Chapter VIII.2
buffy coat smear : Chapter VI.16
bulbar palsy : Chapter XVIII.6
bulimia : Chapter XX.5
bulla : Chapter XXI.6
bullous impetigo : Chapter VI.2
bunyavirus : Chapter VI.1
Burkholderia cepacia : Chapter VIII.3
Burkitt's lymphoma : Chapter VI.1
burns : Chapter XIV.12
burns : Chapter XXI.4
cachexia : Chapter XX.5
cafe au lait spots : Chapter XVIII.1
cafe au lait spots : Chapter XVIII.11
calcaneal apophysitis : Chapter XIX.8
calcidiol : Chapter XV.6
calcitonin : Chapter XV.6
calcitriol : Chapter XV.6
calcium : Chapter XV.6
calcivirus : Chapter VI.1
calcivirus : Chapter IX.3
calorie requirements : Chapter II.1
calories : Chapter II.3
Calymmatobacterium granulomatis : Chapter VI.21
camphor : Chapter XIV.9
Campylobacter : Chapter IX.3
Campylobacter enteritis : Chapter XVIII.7
cancer : Chapter XII.3
candida : Chapter VI.32
Candida albicans : Chapter VI.32
candida dermatitis : Chapter XXI.6
candida vaginitis : Chapter VI.32
candida vulvovaginitis : Chapter VI.21
candidiasis : Chapter VI.20
canine : Chapter I.12
cannabis : Chapter XX.3
capillary blood gas : Chapter VIII.1
capillary blood gas : Chapter XIV.3
capillary lymphangioma : Chapter X.12
capitation : Chapter I.11
CAP-RAST : Chapter V.3
caput succedaneum : Chapter III.1
car seats : Chapter I.6
carbamates : Chapter XIV.9
carbamazepine : Chapter XVIII.3
carbamazepine : Chapter XVIII.4
carbapenem : Chapter VI.5
carbapenem : Chapter VI.16
carbenicillin : Chapter VI.5
carbohydrate : Chapter II.1
carbohydrate : Chapter II.3
carbon monoxide : Chapter XIV.9
carbon monoxide poisoning : Chapter VIII.1
carbon monoxide poisoning : Chapter XXI.4
carboxyhemoglobin : Chapter VIII.1
cardiac arrest : Chapter XIV.1
cardiac output : Chapter XIV.2
cardiac rhabdomyoma : Chapter XVIII.12
cardiac tamponade : Chapter XIV.1
cardiogenic shock : Chapter VI.17
cardiogenic shock : Chapter XIV.8
cardiomegaly : Chapter VII.1
cardiomegaly : Chapter VII.2
cardiomyopathy : Chapter VII.1
cardiopulmonary arrest : Chapter XIV.1
cardiopulmonary resuscitation : Chapter XIV.1
cardiovascular collapse : Chapter V.2
cardioversion : Chapter VII.6
carditis : Chapter VII.4
carditis : Chapter VII.5
caries : Chapter I.12
case control study : Chapter XXII.3
case report : Chapter XXII.3
casein : Chapter II.2
casein : Chapter II.3
casein : Chapter V.3
cast : Chapter XIX.1
cast padding : Chapter XIX.2
cat scratch disease : Chapter VI.29
cat scratch disease : Chapter VI.34
catalase : Chapter VI.2
catarrhal stage : Chapter VI.10
catecholamine : Chapter XX.3
catecholamines : Chapter XIV.2
catecholamines : Chapter XV.4
categorical data : Chapter XXII.1
cathartics : Chapter XIV.9
cause and effect criteria : Chapter XXII.3
caustics : Chapter XIV.9
cavernous lymphangiomas : Chapter X.12
cavernous sinus thrombosis : Chapter VI.7
CBC : Chapter III.10
CBC : Chapter XI.1
CCAM (congenital cystic adenomatoid malformation) : Chapter VIII.9
CD4 lymphocytes : Chapter VI.20
cefaclor : Chapter VI.5
cefazolin : Chapter VI.5
cefotaxime : Chapter VI.5
cefotaxime : Chapter XVII.1
cefotetan : Chapter VI.5
cefoxitin : Chapter VI.5
ceftazidime : Chapter VI.5
ceftriaxone : Chapter VI.5
ceftriaxone : Chapter VI.21
ceftriaxone : Chapter XVII.1
cefuroxime : Chapter VI.5
celiac disease : Chapter IX.12
celiac sprue : Chapter IX.12
cellulitis : Chapter VI.2
cellulitis : Chapter VI.5
cellulitis : Chapter VI.13
cellulitis : Chapter VI.33
cellulitis : Chapter XVII.4
cementum : Chapter I.12
Centers for Medicare and Medicaid Services (CMS) : Chapter I.11
centipede : Chapter XXI.5
central hypoventilation syndrome : Chapter VIII.11
central venous catheter : Chapter VI.2
cephalexin : Chapter VI.5
cephalosporin : Chapter VI.2
cephalosporin : Chapter VI.16
cephalosporin generation : Chapter VI.5
cephalosporins : Chapter VI.5
cephalohematoma : Chapter III.1
cerebellar function : Chapter XVIII.1
cerebral edema : Chapter XIV.12
cerebral edema : Chapter XVIII.17
cerebral heterotopia : Chapter XVIII.16
cerebral palsy : Chapter I.8
cerebral palsy : Chapter VIII.4
cerebral palsy : Chapter XVIII.2
cerebral perfusion pressure : Chapter XVIII.13
cerebral perfusion pressure : Chapter XVIII.17
cerebral spinal fluid (CSF) : Chapter VI.14
cerebritis : Chapter XVI.1
cervical cancer : Chapter VI.21
cervical cerclage : Chapter III.4
cervical spine injury : Chapter XIV.8
cervicitis : Chapter VI.21
cestodes (tapeworms) : Chapter VI.31
Chagas disease : Chapter VI.31
chalazion : Chapter XVII.4
chamomile tea : Chapter IX.1
chancroid : Chapter VI.21
charcoal : Chapter XIV.9
Chediak-Higashi syndrome : Chapter V.5
Chediak-Higashi syndrome : Chapter XI.8
cheilitis : Chapter XXI.1
cheilosis : Chapter II.6
chelation therapy : Chapter XI.2
chemical conjunctivitis : Chapter XVII.1
chemical conjunctivitis : Chapter XVII.4
chemotherapy : Chapter XII.1
chest compressions : Chapter III.3
chest physical therapy : Chapter VIII.3
chest syndrome : Chapter XI.3
chest tube : Chapter XIV.7
chest x-ray : Chapter III.10
Chiari malformation : Chapter XVIII.9
Chiari malformation : Chapter XVIII.16
chickenpox : Chapter VI.1
chickenpox : Chapter VI.22
chickenpox : Chapter XXI.6
chickenpox vaccine : Chapter I.4
child abuse : Chapter VIII.12
child abuse : Chapter XIV.8
child abuse : Chapter XIV.12
child abuse : Chapter XXI.4
child development : Chapter I.3
child neglect : Chapter II.5
child neglect : Chapter XIV.12
childhood disintegrative disorder : Chapter I.9
chin lift : Chapter XIV.1
Chinese restaurant syndrome : Chapter V.3
Chi-square : Chapter XXII.1
Chlamydia : Chapter VI.2
Chlamydia : Chapter VI.5
Chlamydia : Chapter VI.10
Chlamydia : Chapter VI.11
Chlamydia : Chapter XVII.1
Chlamydia : Chapter XX.7
Chlamydia trachomatis : Chapter VI.21
Chlamydia trachomatis : Chapter XVII.4
chlamydial conjunctivitis : Chapter XVII.4
chloramphenicol : Chapter VI.5
chloroquine : Chapter VI.30
choking episode : Chapter VIII.6
cholera : Chapter IX.3
cholestasis : Chapter IX.4
cholestasis : Chapter IX.5
cholesteatoma : Chapter VI.6
cholinergic synapses : Chapter XVIII.6
cholinergics : Chapter XIV.9
chondrolysis : Chapter XIX.6
chorda tympani : Chapter XVIII.1
chordee : Chapter XIII.12
chorea : Chapter VII.4
choreoathetoid CP : Chapter XVIII.2
chorioamnionitis : Chapter III.10
chorioamnionitis : Chapter VI.2
chorionic villus sampling : Chapter IV.1
chorioretinitis : Chapter III.11
choroid : Chapter XVII.2
Christmas disease : Chapter XI.6
chromosomal breakage syndromes : Chapter IV.7
chronic active hepatitis : Chapter IX.11
chronic granulomatous disease (CGD) : Chapter V.5
chronic granulomatous disease (CGD) : Chapter XI.8
chronic hepatitis : Chapter IX.5
chronic lung disease : Chapter VIII.4
chronic mucocutaneous candidiasis : Chapter V.5
chronic obstructive pulmonary disease : Chapter VIII.1
chronic osteomyelitis : Chapter XIX.4
Chvostek sign : Chapter XV.6
ciclopirox : Chapter VI.32
cigarette smoking : Chapter XX.3
ciliary body : Chapter XVII.2
cimetidine : Chapter V.2
ciprofloxacin : Chapter VI.5
circadian rhythm dyssomnia : Chapter VIII.11
circumcision : Chapter III.1
circumcision : Chapter XIII.8
cirrhosis : Chapter VIII.3
clarithromycin : Chapter VI.5
classic hemophilia : Chapter XI.6
clavulanic acid : Chapter VI.2
clavulanic acid : Chapter VI.5
CLD : Chapter VIII.4
cleft lip : Chapter X.10
cleft palate : Chapter X.10
clindamycin : Chapter VI.5
clindamycin : Chapter VI.18
clindamycin : Chapter XXI.2
clinical trial : Chapter XXII.3
clonidine : Chapter XIV.9
Clonorchis : Chapter VI.31
closed fracture : Chapter XIX.1
closed reduction : Chapter XIX.1
Clostridium : Chapter VI.2
Clostridium botulinum : Chapter VI.2
Clostridium botulinum : Chapter XVIII.6
Clostridium difficile : Chapter VI.2
Clostridium difficile : Chapter VI.5
Clostridium perfringens : Chapter VI.2
Clostridium tetani : Chapter VI.2
clotrimazole : Chapter VI.32
clotrimazole : Chapter XXI.6
cloxacillin : Chapter VI.5
clubbing : Chapter VIII.3
clubbing : Chapter VIII.5
CMV : Chapter III.10
CMV : Chapter III.11
CMV : Chapter VI.1
CMV : Chapter VI.15
CMV : Chapter VI.34
CMV : Chapter XI.7
CNS hemorrhage : Chapter VI.10
coagulase : Chapter VI.2
coarctation of the aorta : Chapter VII.2
cobalt blue light : Chapter XVII.5
Cobb angle : Chapter XIX.3
cocaine : Chapter XIV.9
cocaine : Chapter XX.3
cockroach antigen : Chapter VIII.2
cohort study : Chapter XXII.3
coin : Chapter IX.7
colic : Chapter II.3
colic : Chapter IX.1
colic : Chapter IX.2
colitis : Chapter IX.3
colitis : Chapter IX.10
collagen : Chapter IV.5
collateral ligament injury : Chapter XIX.7
colloid : Chapter XIV.2
coloboma : Chapter XVII.2
colonic polyps : Chapter IX.10
combined oral contraceptives : Chapter XX.7
comedones : Chapter XXI.2
comminuted fracture : Chapter XIX.1
common variable immunodeficiency (CVID) : Chapter V.5
communicating hydrocele : Chapter X.2
communicating hydrocephalus : Chapter XVIII.9
communicating pneumothorax : Chapter XIV.7
compartment syndrome : Chapter XIX.2
compartment syndrome : Chapter XXI.4
complement deficiency : Chapter V.5
complete fracture : Chapter XIX.1
compound fracture : Chapter XIX.1
compound nevi : Chapter XXI.3
concussion : Chapter XVIII.13
conditioned play audiometry (CPA) : Chapter I.5
condoms : Chapter VI.21
condoms : Chapter XX.7
conduct disorder : Chapter I.10
conduct disorder : Chapter XX.4
conductive hearing loss : Chapter I.5
conductive hearing loss : Chapter VI.6
condyloma acuminata : Chapter XXI.6
condyloma acuminata : Chapter VI.1
condyloma acuminata : Chapter VI.21
condyloma lata : Chapter VI.21
confetti skin lesions : Chapter XVIII.12
confidence interval : Chapter XXII.1
confidence interval : Chapter XXII.2
confidentiality : Chapter XX.7
confounding variable : Chapter XXII.3
congenital adrenal hyperplasia : Chapter III.1
congenital adrenal hyperplasia : Chapter XIII.11
congenital adrenal hyperplasia : Chapter XV.4
congenital anomalies : Chapter IV.2
congenital CMV : Chapter III.11
congenital dislocated hip : Chapter XIX.6
congenital dyserythropoietic anemia (CDEA) : Chapter XI.1
congenital encephalitis : Chapter VI.15
congenital heart block : Chapter VII.6
congenital heart disease : Chapter III.6
congenital heart disease : Chapter III.7
congenital heart disease : Chapter III.8
congenital herpes : Chapter III.11
congenital hip dislocation : Chapter XIX.6
congenital HIV : Chapter III.11
congenital hypothyroidism : Chapter XV.2
congenital infection : Chapter III.9
congenital infection : Chapter III.11
congenital infection : Chapter VI.1
congenital intestinal aganglionosis : Chapter IX.9
congenital megacolon : Chapter IX.9
congenital muscular dystrophy : Chapter XVIII.14
congenital rubella : Chapter III.11
congenital short stature : Chapter I.2
congenital syphilis : Chapter III.11
congenital toxoplasmosis : Chapter III.11
congestive heart failure : Chapter VII.1
congestive heart failure : Chapter VII.2
congestive heart failure : Chapter VII.4
congestive heart failure : Chapter VII.5
congestive heart failure : Chapter VII.6
conjugated bilirubin : Chapter III.2
conjunctiva : Chapter XVII.2
conjunctival edema : Chapter V.2
conjunctivitis : Chapter V.1
conjunctivitis : Chapter VI.1
conjunctivitis : Chapter XVII.1
conjunctivitis : Chapter XVII.4
connective tissue disorders : Chapter IV.5
constipation : Chapter IX.2
constipation : Chapter IX.8
constipation : Chapter XII.4
constitutional growth delay : Chapter I.2
constitutional growth delay : Chapter II.5
constitutional growth delay : Chapter XV.3
constitutional growth delay : Chapter XX.1
contact dermatitis : Chapter XXI.6
continuous data : Chapter XXII.1
continuous positive airway pressure : Chapter III.5
continuous positive airway pressure : Chapter III.6
contraception : Chapter XX.7
contraceptive patch : Chapter XX.7
contraceptive sponge : Chapter XX.7
contractility : Chapter XIV.2
contrast enema : Chapter X.4
convalescent stage : Chapter VI.10
convulsion : Chapter XVIII.3
convulsion : Chapter XVIII.5
Cooley's anemia : Chapter XI.2
Coombs test : Chapter XI.7
Coombs test : Chapter III.2
co-oximetry : Chapter VIII.1
COPD : Chapter VIII.1
copolymer I : Chapter XVIII.8
cor pulmonale : Chapter VIII.3
cor pulmonale : Chapter VIII.4
cord hydrocele : Chapter X.2
core temperature : Chapter VI.3
corn syrup : Chapter II.3
cornea : Chapter XVII.2
corneal abrasion : Chapter XVII.5
corneal light reflex : Chapter XVII.2
corneal reflection test : Chapter XVII.3
corneal reflex : Chapter XVIII.1
corneal ulcer : Chapter XVII.5
coronary aneurysms : Chapter VI.17
coronavirus : Chapter VI.1
coronavirus : Chapter VI.9
corporal punishment : Chapter I.6
corporal punishment : Chapter XX.4
corticospinal tract : Chapter XVIII.1
corticosteroids : Chapter V.1
corticosteroids : Chapter V.2
corticosteroids : Chapter V.4
corticosteroids : Chapter VIII.2
corticosteroids : Chapter VIII.4
corticosteroids : Chapter IX.11
corticosteroids : Chapter XIV.3
corticosteroids : Chapter XV.3
corticosteroids : Chapter XV.4
corticosteroids : Chapter XVI.1
corticosteroids : Chapter XVII.4
corticosteroids : Chapter XVIII.8
corticosteroids : Chapter XXI.1
corticosteroids : Chapter XXI.6
corticosteroids. : Chapter XVIII.14
cortisol : Chapter V.4
cortisol : Chapter XV.4
cortisol deficiency : Chapter III.8
Corynebacteria : Chapter VI.2
Corynebacteria diphtheria : Chapter VI.2
co-sleeping : Chapter VIII.12
coumadin : Chapter IV.2
coumadin : Chapter XI.6
cover test : Chapter XVII.2
cover-uncover test : Chapter XVII.3
cowpox : Chapter VI.1
cow's milk allergy : Chapter II.3
cow's milk allergy : Chapter XI.1
cow's milk allergy : Chapter XI.4
cow's milk anemia : Chapter XI.1
cows' milk protein sensitivity : Chapter IX.10
coxsackie virus : Chapter VI.1
coxsackie virus : Chapter VI.9
coxsackie virus : Chapter VI.22
CPAP (continuous positive airway pressure) : Chapter III.5
CPAP (continuous positive airway pressure) : Chapter VII.1
CPAP (continuous positive airway pressure) : Chapter XIV.3
CPT codes : Chapter I.11
cradle cap : Chapter XXI.1
cramps : Chapter IX.2
cranial nerves : Chapter XVIII.1
craniofacial malformation : Chapter X.10
craniopharyngioma : Chapter XVIII.18
craniosynostosis : Chapter X.10
craniosynostosis : Chapter XVIII.1
craniotabes : Chapter III.1
C-reactive protein : Chapter XIX.4
cremasteric reflex : Chapter XIII.10
crescent sign : Chapter X.4
Cri du Chat syndrome : Chapter VIII.5
Crohn's disease : Chapter IX.11
cromolyn : Chapter V.1
cromolyn : Chapter VIII.2
cromolyn : Chapter VIII.4
crossed eyes : Chapter XVII.3
crossmatch : Chapter XI.7
croup : Chapter VI.1
croup : Chapter VI.12
croup : Chapter XIV.3
Crouzon's disease : Chapter X.10
CRP : Chapter XIX.4
cruciate ligament injury : Chapter XIX.7
crusts : Chapter XXI.6
crying : Chapter IX.1
cryoglobulinemic vasculitis : Chapter XVI.3
crypt abscesses : Chapter IX.11
cryptorchidism : Chapter XIII.12
cryptosporidiosis : Chapter IX.3
cryptosporidium : Chapter VI.31
cryptosporidium : Chapter IX.3
crystalloid : Chapter XIV.2
crystalloid : Chapter XIV.8
CSF : Chapter III.10
CT scan : Chapter XIX.4
currant jelly stool : Chapter X.4
curved blade : Chapter XIV.4
Cushing's disease : Chapter XV.4
Cushing's syndrome : Chapter V.4
Cushing's syndrome : Chapter XV.4
Cushing's triad : Chapter XVIII.13
cutaneous leukocytoclastic vasculitis : Chapter XVI.3
CXR : Chapter III.10
cyanide : Chapter XIV.9
cyanocobalamin : Chapter II.6
cyanosis : Chapter III.7
cyanosis : Chapter III.10
cyanosis : Chapter VII.3
cyanosis : Chapter VIII.1
cyanosis : Chapter VIII.4
cyanotic congenital heart disease : Chapter III.6
cyanotic congenital heart disease : Chapter VII.3
cyclophosphamide : Chapter XVI.1
cycloplegic : Chapter XVII.5
cycloserine : Chapter VI.19
cyclosporin(e) : Chapter IX.11
cyclosporin(e) : Chapter XVI.1
cyclosporin(e) : Chapter XXI.1
cyst : Chapter XXI.6
cystic adenomatoid malformation : Chapter VIII.9
cysticercosis : Chapter VI.31
cystic fibrosis : Chapter IV.1
cystic fibrosis : Chapter VIII.3
cystic fibrosis : Chapter VIII.5
cystic fibrosis : Chapter IX.5
cystic hygroma : Chapter X.12
cystic kidneys : Chapter XIII.3
cystic lymphangiomas : Chapter X.12
cystitis : Chapter XIII.6
cytochrome p450 : Chapter IX.5
cytogenetics : Chapter XII.2
cytomegalovirus (CMV) : Chapter III.10
cytomegalovirus (CMV) : Chapter III.11
cytomegalovirus (CMV) : Chapter VI.1
cytomegalovirus (CMV) : Chapter VI.15
cytomegalovirus (CMV) : Chapter VI.34
cytomegalovirus (CMV) : Chapter XI.7
dactylitis : Chapter XI.3
Dandy Walker malformation : Chapter XVIII.9
DDAVP : Chapter XI.6
DDAVP : Chapter XIII.9
DDAVP : Chapter XV.5
D-dimer : Chapter XI.6
DDST : Chapter I.3
decongestants : Chapter XIV.9
decontamination : Chapter XIV.9
decubitus CXR views : Chapter VIII.6
deer tick : Chapter VI.27
DEET : Chapter VI.27
deferoxamine : Chapter XI.2
deferoxamine : Chapter XIV.11
defibrillation : Chapter XIV.1
degenerative hip disease : Chapter XIX.6
dehydration : Chapter II.4
dehydration : Chapter IX.3
dehydration : Chapter X.3
dehydration : Chapter X.8
dehydrocholesterol : Chapter II.6
delayed hypersensitivity : Chapter V.5
delayed meconium passage : Chapter IX.9
delayed meconium : Chapter IX.8
delayed primary closure : Chapter X.1
deletion : Chapter IV.7
delirium : Chapter XX.3
delivery room resuscitation : Chapter III.3
delta agent : Chapter IX.5
demyelination : Chapter XVIII.7
demyelination : Chapter XVIII.8
dengue fever : Chapter VI.1
dense body deficiency : Chapter XI.6
dental care : Chapter I.6
dental caries : Chapter I.6
dental decay : Chapter I.12
dental home : Chapter I.6
dentin : Chapter I.12
dentinogenesis imperfecta : Chapter I.12
Denver developmental screening test : Chapter I.3
Denys-Drash syndrome : Chapter XII.3
deoxycorticosterone acetate (DOCA) : Chapter XV.4
depo(t) medroxyprogesterone (Provera) : Chapter XX.7
depressed skull fracture : Chapter XVIII.13
depression : Chapter XX.4
Dermacentor andersoni : Chapter VI.26
Dermacentor variabilis : Chapter VI.26
dermatitis : Chapter XXI.1
dermatomyositis : Chapter XVIII.15
dermatophyte : Chapter VI.32
dermis : Chapter XXI.6
descriptive statistics : Chapter XXII.1
desipramine : Chapter I.10
desmopressin : Chapter XI.6
desmopressin : Chapter XV.5
detoxification : Chapter XIV.9
development : Chapter I.7
developmental brain anomaly : Chapter XVIII.16
developmental delay : Chapter I.3
developmental dysplasia of the hip : Chapter XIX.6
developmental language disorder : Chapter I.9
developmental screening : Chapter I.3
dexamethasone : Chapter V.4
dexamethasone : Chapter VIII.2
dexamethasone : Chapter VIII.4
dextroamphetamine : Chapter I.10
DFA : Chapter VI.10
diabetes : Chapter IV.2
diabetes : Chapter XIII.9
diabetes insipidus : Chapter XV.5
diabetes mellitus : Chapter VIII.3
diabetes mellitus : Chapter XV.1
diabetic ketoacidosis : Chapter VIII.1
diabetic ketoacidosis : Chapter IX.2
diabetic ketoacidosis : Chapter XV.1
dialysis : Chapter XIII.4
dialysis : Chapter XIII.5
Diamond-Blackfan anemia : Chapter XI.1
Diamond-Blackfan anemia : Chapter XI.4
diaper dermatitis : Chapter XXI.6
diaphragm : Chapter XX.7
diaphragmatic hernia : Chapter III.6
diaphragmatic hernia : Chapter III.7
diaphragmatic hernia : Chapter X.7
diaphysis : Chapter XIX.1
diaphysis : Chapter XIX.4
diarrhea : Chapter II.4
diarrhea : Chapter IX.3
diarrhea : Chapter XIII.5
diazepam : Chapter XVIII.3
diazepam : Chapter XVIII.5
DIC : Chapter VI.16
dicloxacillin : Chapter VI.5
dietary protein enterocolitis : Chapter V.3
diethylcarbamazine : Chapter VI.31
DiGeorge anomaly : Chapter V.5
DiGeorge syndrome : Chapter XV.6
digital clubbing : Chapter VIII.3
digoxin : Chapter VII.1
digoxin : Chapter XIV.9
diphenhydramine : Chapter V.2
diphenhydramine : Chapter XIV.9
Diphtheria : Chapter VI.2
diphtheria toxoid : Chapter I.4
diphtheria toxoid : Chapter VI.2
Diphtheroids : Chapter VI.2
Diphyllobothrium latum : Chapter VI.31
direct antibody test : Chapter III.2
direct antibody test (DAT) : Chapter XI.7
direct bilirubin : Chapter III.2
direct fluorescent antibody : Chapter VI.10
disability : Chapter I.8
discipline : Chapter I.6
discipline : Chapter I.7
discoid rash : Chapter XVI.1
DISIDA scan : Chapter IX.4
disk battery : Chapter IX.7
dislocation : Chapter XIX.7
disseminated intravascular coagulation : Chapter VI.16
disseminated intravascular coagulation (DIC) : Chapter XI.6
distortion product otoacoustic emissions (DPOAE) : Chapter I.5
diuretics : Chapter VIII.4
diverticulitis : Chapter IX.13
DKA : Chapter XV.1
D-lysergic acid diethylamide : Chapter XX.3
DNA chip technology : Chapter IV.6
DNA virus : Chapter VI.1
dobutamine : Chapter VI.16
dobutamine : Chapter VII.1
dobutamine : Chapter XIV.2
dog tick : Chapter VI.26
doll's eyes : Chapter XVIII.1
dominant inheritance : Chapter IV.4
dopamine : Chapter I.10
dopamine : Chapter VI.16
dopamine : Chapter VII.1
dopamine : Chapter XIV.2
Doppler ultrasonography : Chapter XIII.10
dorsal columns : Chapter XVIII.1
double aortic arch : Chapter VII.7
double blinding : Chapter XXII.2
double blinding : Chapter XXII.3
double bubble sign : Chapter X.9
double stranded DNA virus : Chapter VI.1
Down Syndrome : Chapter I.2
Down syndrome : Chapter IV.3
Down syndrome : Chapter XI.5
downers : Chapter XX.3
doxycycline : Chapter VI.5
doxycycline : Chapter VI.21
doxycycline : Chapter VI.26
doxycycline : Chapter VI.30
doxycycline : Chapter XXI.2
DPT vaccine : Chapter I.4
Dracunculus medinensis (Guinea worm) : Chapter VI.31.
draw and tag : Chapter XI.7
drooling : Chapter IX.7
drowning : Chapter I.6
drowning : Chapter XIV.6
drug abuse : Chapter XX.3
drug addiction : Chapter XX.3
drug dependence : Chapter XX.3
dry drowning : Chapter XIV.6
DSM-IV : Chapter I.10
dT vaccine : Chapter I.4
DTaP vaccine : Chapter VI.10
DTP vaccine : Chapter VI.10
DUB : Chapter XX.7
Duchenne muscular dystrophy : Chapter XVIII.14
duck embryo vaccine (DEV) : Chapter VI.25
dumb rabies : Chapter VI.25
duodenal atresia : Chapter X.9
dust mite antigens : Chapter VIII.2
dysdiadochokinesia : Chapter XVIII.1
dysentery : Chapter VI.2
dysentery : Chapter IX.3
dysentery : Chapter XIII.5
dysfunctional uterine bleeding : Chapter XX.7
dysgenetic gonads : Chapter XIII.11
dyskeratosis congenita : Chapter XI.4
dyskinetic CP : Chapter XVIII.2
dysmenorrhea : Chapter XX.7
dysphagia : Chapter VII.7
dysphagia : Chapter IX.7
dyspnea : Chapter III.7
dysrhythmia : Chapter VII.6
dyssomnia : Chapter VIII.11
dystrophin : Chapter XVIII.14
dysuria : Chapter XIII.10
E. coli : Chapter III.10
E. coli : Chapter IX.3
E. coli O157 : Chapter VI.2
E. coli O157 : Chapter XIII.5
Eagle effect : Chapter VI.18
Eagle-Barrett Syndrome : Chapter XIII.7
early childhood caries : Chapter I.12
eastern equine encephalitis : Chapter VI.1
eastern equine encephalitis : Chapter VI.15
eating disorders : Chapter XX.5
EBM : Chapter XXII.2
Ebola virus : Chapter VI.1
Ebstein anomaly : Chapter VII.3
EBV : Chapter VI.1
EBV : Chapter VI.23
echovirus : Chapter VI.1
echovirus : Chapter VI.22
ECMO : Chapter III.6
ECMO : Chapter III.7
ECMO : Chapter X.7
ecstasy : Chapter XX.3
ecthyma gangrenosum : Chapter VI.16
eczema : Chapter XXI.1
edema : Chapter XIII.1
Edwards syndrome : Chapter IV.3
EEG : Chapter III.9
EEG : Chapter XVIII.3
EEG : Chapter XVIII.4
EEG : Chapter XVIII.5
EEG : Chapter XVIII.12
EES : Chapter VI.5
egg allergy : Chapter V.3
Ehlers-Danlos syndrome : Chapter IV.5
Ehlers-Danlos syndrome : Chapter VIII.5
Ehrlichiosis : Chapter VI.26
Eisenmenger's syndrome : Chapter VII.3
elastin : Chapter IV.5
elbow tendonitis : Chapter XIX.8
electroencephalogram (EEG) : Chapter XVIII.4
electrolytes : Chapter II.4
electromechanical dissociation : Chapter XIV.1
electromyography : Chapter XVIII.6
electromyography : Chapter XVIII.7
electromyography : Chapter XVIII.14
electromyography : Chapter XVIII.15
elephantiasis : Chapter VI.31
ELISA : Chapter VI.20
emboli : Chapter VII.5
EMD : Chapter XIV.1
emergency contraception : Chapter XX.7
emergency medical services (EMS) : Chapter XIV.1
Emery-Dreifuss muscular dystrophy : Chapter XVIII.14
EMG : Chapter XVIII.14
emphysema : Chapter VIII.1
empiric antibiotics : Chapter III.10
empiric antibiotics : Chapter VI.5
empyema : Chapter VI.11
EMS : Chapter XIV.1
enamel : Chapter I.12
enanthem : Chapter VI.22
encephalitis : Chapter VI.1
encephalitis : Chapter VI.15
encephalitis : Chapter VI.25
encephalitis : Chapter XVIII.5
encephalopathy : Chapter IV.4
encephalopathy : Chapter VI.10
encephalopathy : Chapter VI.29
encephalopathy : Chapter XVIII.17
encopresis : Chapter IX.8
end tidal CO2 : Chapter XIV.4
endocarditis : Chapter VI.2
endocarditis : Chapter VI.4
endocarditis : Chapter VII.5
endocarditis prophylaxis : Chapter VII.5
endometritis : Chapter VI.21
endoscopy : Chapter IX.7
endoscopy : Chapter IX.10
endotoxin : Chapter VI.2
endotoxin : Chapter VI.18
endotoxin shock : Chapter VI.16
endotracheal intubation : Chapter XIV.1
endotracheal intubation : Chapter XIV.4
endotracheal tube : Chapter XIV.1
endotracheal tube : Chapter XIV.4
enema : Chapter IX.8
Entamoeba histolytica : Chapter VI.31
Entamoeba histolytica : Chapter IX.3
enteric adenovirus : Chapter IX.3
enteritis : Chapter IX.3
Enterobacteriaceae : Chapter VI.2
Enterobius vermicularis : Chapter VI.31
enterococcus : Chapter VI.2
enterocolitis : Chapter IX.8
enterocolitis : Chapter IX.9
enteropathogenic E. coli : Chapter VI.2
enterotoxigenic E. coli : Chapter VI.2
enterotoxin : Chapter VI.18
enterotoxin : Chapter IX.3
enterovirus : Chapter VI.1
enuresis : Chapter VIII.11
enuresis : Chapter XIII.9
enuresis : Chapter XV.1
enveloped virus : Chapter VI.1
envenomation : Chapter XXI.5
enzyme deficiency : Chapter IV.4
eosinophilia : Chapter VI.31
eosinophilic gastroenteropathies : Chapter V.3
ependymoma : Chapter XVIII.18
epidemiology : Chapter XXII.3
epidermis : Chapter XXI.6
Epidermophyton : Chapter VI.32
epididymitis : Chapter VI.21
epididymitis : Chapter XIII.10
epidural abscess : Chapter VI.7
epidural hematoma : Chapter XVIII.13
epiglottitis : Chapter VI.12
epiglottitis : Chapter XIV.3
epilepsy : Chapter IV.2
epilepsy : Chapter XVIII.3
epilepsy : Chapter XVIII.4
epilepsy : Chapter XVIII.5
epilepsy : Chapter XVIII.11
epilepsy : Chapter XVIII.12
epinephrine : Chapter III.3
epinephrine : Chapter V.2
epinephrine : Chapter VI.12
epinephrine : Chapter VI.16
epinephrine : Chapter VIII.2
epinephrine : Chapter XIV.1
epinephrine : Chapter XIV.2
epinephrine : Chapter XIV.3
epiphysis : Chapter XIX.1
episcleritis : Chapter IX.11
epispadias : Chapter XIII.12
epistaxis : Chapter IX.10
epsilon aminocaproic acid : Chapter XI.6
Epstein Barr virus (EBV) : Chapter VI.1
Epstein Barr virus (EBV) : Chapter VI.9
Epstein Barr virus (EBV) : Chapter VI.15
Epstein Barr virus (EBV) : Chapter VI.22
Epstein Barr virus (EBV) : Chapter VI.23
Epstein Barr virus (EBV) : Chapter VI.34
equine encephalitis : Chapter VI.1
erosions : Chapter XXI.6
erysipelas : Chapter VI.13
erythema infectiosum : Chapter VI.1
erythema infectiosum : Chapter VI.22
erythema marginatum : Chapter VII.4
erythema multiforme : Chapter V.2
erythema multiforme : Chapter VI.17
erythema nodosum : Chapter IX.11
erythema toxicum : Chapter XXI.6
erythrocyte sedimentation rate : Chapter XIX.4
erythrocytic schizogony : Chapter VI.30
erythromycin : Chapter VI.5
erythromycin : Chapter VI.10
erythromycin : Chapter XVII.1
erythromycin : Chapter XXI.2
erythromycin estolate : Chapter VI.5
erythromycin ethylsuccinate : Chapter VI.5
erythromycin ophthalmic : Chapter III.1
erythromycin propyl-laurel sulfate : Chapter VI.5
erythropoietin : Chapter VIII.1
erythropoietin : Chapter XI.1
Escherichia coli : Chapter VI.2
esophageal atresia : Chapter X.9
esophageal foreign body : Chapter IX.7
esophageal varices : Chapter IX.10
esophagitis : Chapter IX.6
esophagitis : Chapter IX.10
esophagram : Chapter VII.7
esotropia : Chapter XVII.3
ESR : Chapter XIX.4
ethambutol : Chapter VI.19
ethanol : Chapter XIV.9
ethionamide : Chapter VI.19
ethmoid sinus : Chapter VI.7
ethylene glycol : Chapter XIV.9
euploidy : Chapter IV.7
eustachian tube : Chapter VI.6
evidence-based medicine : Chapter XXII.2
exanthem : Chapter VI.22
exanthem subitum : Chapter VI.22
exchange transfusion : Chapter III.2
exchange transfusion : Chapter III.8
excoriations : Chapter XXI.6
exocrine dysfunction : Chapter VIII.3
exotoxin : Chapter VI.2
exotoxin shock : Chapter VI.16
exotropia : Chapter XVII.3
experimental design : Chapter XXII.3
expiratory CXR view : Chapter VIII.6
external fixation : Chapter XIX.1
external rotation method of shoulder reduction : Chapter XIX.7
extracellular fluid (ECF) : Chapter II.4
extracorporeal membrane oxygenation : Chapter X.7
extrahepatic biliary atresia : Chapter IX.4
extramedullary hematopoiesis : Chapter XI.2
extraocular movements : Chapter XVIII.1
extravaginal torsion : Chapter XIII.10
eye patch : Chapter XVII.5
eye patching : Chapter XVII.3
eye prophylaxis : Chapter XVII.1
facial nerve (CN VII) : Chapter XVIII.1
Facioscapulohumeral dystrophy : Chapter XVIII.14
Fagan nomogram : Chapter XXII.2
failure to thrive : Chapter I.2
failure to thrive : Chapter II.1
failure to thrive : Chapter II.5
failure to thrive : Chapter VI.20
failure to thrive : Chapter VIII.3
failure to thrive : Chapter VIII.10
failure to thrive : Chapter IX.6
failure to thrive : Chapter IX.12
failure to thrive : Chapter XIV.12
famciclovir : Chapter VI.21
familial glomerulonephritis : Chapter XIII.1
familial short stature : Chapter I.2
familial short stature : Chapter XV.3
Fanconi anemia : Chapter XVIII.11
Fanconi's anemia : Chapter XI.4
fasciitis : Chapter VI.33
fasciola : Chapter VI.31
fat : Chapter II.1
fat : Chapter II.3
fat soluble vitamin deficiency : Chapter VIII.3
fatigue : Chapter XII.4
fatty acid oxidation : Chapter XVIII.17
febrile seizure : Chapter VI.3
febrile seizure : Chapter XVIII.3
febrile seizure, atypical : Chapter XVIII.3
febrile seizure, complex : Chapter XVIII.3
febrile seizure, recurrent : Chapter XVIII.3
febrile seizure, simple : Chapter XVIII.3
fecalith : Chapter X.3
fee for service (FFS) : Chapter I.11
female condoms : Chapter XX.7
ferritin : Chapter XI.1
fetal alcohol syndrome : Chapter III.4
fetal alcohol syndrome : Chapter IV.2
fetal distress : Chapter III.10
fetal hydrops : Chapter XI.2
fetal malformation : Chapter III.3
FEV1 : Chapter VIII.2
fever : Chapter VI.3
fiberglass : Chapter XIX.2
Fifth's disease : Chapter VI.1
Fifth's disease : Chapter VI.22
filovirus : Chapter VI.1
finger sweep : Chapter VIII.6
FiO2 : Chapter XIV.5
first degree burns : Chapter XXI.4
fish allergy : Chapter V.3
fissures : Chapter XXI.6
Fitz-Hugh-Curtis syndrome : Chapter VI.21
flaccidity : Chapter XVIII.6
flaccidity : Chapter XVIII.7
flavivirus : Chapter VI.1
flesh eating bacteria : Chapter VI.13
fluconazole : Chapter VI.32
fludrocortisone : Chapter XV.4
fluid loss : Chapter XXI.4
fluid requirements : Chapter II.1
fluids : Chapter II.4
flunisolide : Chapter VIII.2
fluorescein : Chapter XVII.5
fluoridation : Chapter II.1
fluoride : Chapter I.6
fluoride : Chapter I.12
fluorosis : Chapter I.12
fluticasone : Chapter VIII.2
focal segmental glomerulosclerosis : Chapter XIII.2
folate deficiency : Chapter XI.1
Foley catheter removal : Chapter IX.7
fomepizole : Chapter XIV.9
Fontan procedure : Chapter VII.3
food allergy : Chapter V.3
food borne botulism : Chapter XVIII.6
food borne infection : Chapter IX.3
food intolerance : Chapter V.3
food poisoning : Chapter VI.2
food poisoning : Chapter IX.3
foramen of Bochdalek : Chapter X.7
forceps delivery : Chapter III.3
Forchheimer's sign : Chapter VI.22
foregut cyst : Chapter VIII.9
foreign body : Chapter IX.7
foreign body : Chapter X.1
foreign body aspiration : Chapter VIII.6
foreign body aspiration : Chapter XIV.3
formoterol : Chapter VIII.2
formula : Chapter II.1
formula : Chapter II.3
fourth degree burn : Chapter XXI.4
fovea : Chapter XVII.2
fracture : Chapter XIV.12
fracture : Chapter XIX.1
Fragile X syndrome : Chapter IV.3
fresh frozen plasma : Chapter XIV.2
frontal osteomyelitis : Chapter VI.7
frontal sinus : Chapter VI.7
FTA-Abs : Chapter VI.21
FTT : Chapter II.5
full thickness burn : Chapter XXI.4
functional asplenia : Chapter XI.3
funduscopy : Chapter XVII.2
furious rabies : Chapter VI.25
furosemide : Chapter VIII.4
furosemide : Chapter XV.4
G6PD deficiency : Chapter III.2
G6PD deficiency : Chapter IV.1
G6PD deficiency : Chapter VI.5
G6PD deficiency : Chapter VI.26
G6PD deficiency : Chapter XI.1
GABA : Chapter XX.3
gag reflex : Chapter XVIII.1
galactosemia : Chapter II.3
galactosemia : Chapter III.1
galactosemia : Chapter III.2
galactosemia : Chapter III.8
galactosemia : Chapter IV.4
galactosemia : Chapter IX.5
Galeazzi sign : Chapter XIX.6
gamma amino butyric acid (GABA) : Chapter XX.3
gamma globulin : Chapter IX.5
gamma hemolytic strep : Chapter VI.2
gamma-glutamyl transpeptidase (GGT) : Chapter IX.5
gamma-hydroxybutyrate : Chapter XX.3
Gardnerella vaginalis : Chapter VI.21
gas gangrene : Chapter VI.33
gastric erosion : Chapter IX.10
gastric foreign body : Chapter IX.7
gastric lavage : Chapter XIV.9
gastric lavage : Chapter XIV.10
gastritis : Chapter IX.10
gastroenteritis : Chapter II.4
gastroenteritis : Chapter VI.1
gastroenteritis : Chapter VI.2
gastroenteritis : Chapter IX.2
gastroenteritis : Chapter IX.3
gastroesophageal reflux : Chapter VIII.4
gastroesophageal reflux : Chapter VIII.5
gastroesophageal reflux : Chapter IX.6
gastroesophageal reflux : Chapter XVIII.2
gastroschisis : Chapter X.6
GBS prophylaxis : Chapter III.10
gender identity : Chapter XX.6
gene therapy : Chapter IV.6
generalized seizure : Chapter XVIII.4
genetic counseling : Chapter XVIII.11
genetic counseling : Chapter XVIII.12
genetic screening : Chapter IV.1
genetic testing : Chapter IV.6
genital herpes : Chapter VI.1
genital herpes : Chapter VI.21
gentamicin : Chapter VI.5
gentian violet : Chapter VI.32
GER : Chapter VIII.4
GER : Chapter IX.6
German measles : Chapter VI.22
germinal matrix hemorrhage : Chapter III.5
GHB : Chapter XX.3
GI bleeding : Chapter IX.10
GI bleeding : Chapter IX.13
GI decontamination : Chapter XIV.9
giant platelet syndrome : Chapter XI.6
Giardia lamblia : Chapter VI.31
Giardia lamblia : Chapter IX.3
giardiasis : Chapter VI.31
giardiasis : Chapter IX.3
giardiasis : Chapter IX.12
gingivitis : Chapter VI.9
gingivostomatitis : Chapter VI.9
glanuloplasty : Chapter XIII.12
Glanzmann thrombasthenia : Chapter XI.6
glargine insulin : Chapter XV.1
Glasgow Coma Scale : Chapter XVIII.13
glaucoma : Chapter XVII.2
glaucoma : Chapter XVII.5
Glenn procedure : Chapter VII.3
glioma : Chapter XVIII.18
glomerulonephritis : Chapter VI.2
glomerulonephritis : Chapter XIII.1
glomerulonephritis : Chapter XIII.5
glossitis : Chapter II.6
glossitis : Chapter VI.9
glossopharyngeal nerve (CN IX) : Chapter XVIII.1
glucagon deficiency : Chapter III.8
glucocorticoids : Chapter V.4
glucocorticoids : Chapter VIII.2
glucocorticoids : Chapter XV.4
gluconeogenesis : Chapter III.8
glucose : Chapter III.8
glucose : Chapter XIV.9
glucose polymer : Chapter II.3
glue sniffing : Chapter XX.3
gluten enteropathy : Chapter IX.12
gluten sensitivity : Chapter IX.12
glycerin : Chapter IX.8
glycogen : Chapter III.8
glycosuria : Chapter XV.1
glycosylated hemoglobin : Chapter XV.1
gold standard : Chapter XXII.3
Gomco : Chapter XIII.8
gonadal dysgenesis : Chapter XIII.11
gonococcal conjunctivitis : Chapter XVII.4
gonorrhea : Chapter VI.2
gonorrhea : Chapter VI.21
gonorrhea : Chapter XVII.1
gonorrhea : Chapter XVII.4
gonorrhea : Chapter XIX.5
gonorrhea : Chapter XX.7
Goodpasture's disease : Chapter VIII.7
Goodpasture's disease : Chapter XIII.1
Gowers' maneuver : Chapter XVIII.14
Gowers' sign : Chapter XVIII.15
graft versus host disease : Chapter V.6
graft versus host disease : Chapter XII.1
gram negative bacilli : Chapter VI.2
gram negative cocci : Chapter VI.2
gram negative coccobacilli : Chapter VI.2
gram negative organisms : Chapter VI.5
gram negative pleomorphic rods : Chapter VI.2
gram negative rods : Chapter VI.2
gram positive bacilli : Chapter VI.2
gram positive cocci : Chapter VI.2
gram positive organisms : Chapter VI.5
gram positive rods : Chapter VI.2
gram stain : Chapter VI.2
grand mal seizure : Chapter XVIII.4
granuloma inguinale : Chapter VI.21
Graves' disease : Chapter XV.2
gray matter heterotopia : Chapter XVIII.16
gray platelet syndrome : Chapter XI.6
greenstick fracture : Chapter XIX.1
griseofulvin : Chapter VI.32
group A beta hemolytic strep (group A strep) : Chapter VI.13
group A beta hemolytic strep (group A strep) : Chapter VI.33
group A beta hemolytic strep (group A strep) : Chapter VI.34
group A strep (beta hemolytic) : Chapter VI.2
group A strep (beta hemolytic) : Chapter VI.5
group A strep (beta hemolytic) : Chapter VI.16
group A strep (beta hemolytic) : Chapter VI.18
group B strep : Chapter III.6
group B strep : Chapter VI.2
group B strep : Chapter VI.11
group B strep prophylaxis : Chapter VI.2
group B streptococcus (GBS) : Chapter III.10
group C strep : Chapter VI.2
group D strep : Chapter VI.2
growing pains : Chapter XII.3
growing skull fracture : Chapter XVIII.13
growth : Chapter I.2
growth : Chapter II.5
growth chart : Chapter I.2
growth hormone : Chapter XV.3
growth plate : Chapter XIX.1
growth spurt : Chapter XX.1
guaiac : Chapter IX.10
Guillain-Barre syndrome : Chapter XIV.3
Guillain-Barre syndrome : Chapter XVIII.7
Guillain-Barre syndrome : Chapter XVIII.15
gynecology : Chapter XX.7
Haemophilus : Chapter VI.2
Haemophilus ducreyi : Chapter VI.21
Haemophilus flu : Chapter VI.2
Haemophilus influenzae : Chapter VI.2
Haemophilus influenzae : Chapter VI.7
Haemophilus influenzae B vaccine : Chapter I.4
Haemophilus influenzae, type B : Chapter VI.2
Haemophilus influenzae, type B : Chapter VI.5
Haemophilus influenzae, type B : Chapter VI.12
Haemophilus influenzae, type B : Chapter VI.13
hallucinogens : Chapter XX.3
hamartin : Chapter XVIII.12
Hamman's sign : Chapter XIV.7
hand foot mouth disease : Chapter VI.1
hand foot mouth disease : Chapter VI.9
hand foot mouth disease : Chapter VI.22
haptoglobin : Chapter XI.1
Hashimoto thyroiditis : Chapter XV.2
HATTS : Chapter VI.21
head circumference : Chapter XVIII.1
head lice : Chapter XXI.6
Head Start : Chapter I.8
Health Care Finance Administration (HCFA) : Chapter I.11
health insurance : Chapter I.11
hearing loss : Chapter VI.6
hearing loss : Chapter VI.14
hearing screening : Chapter I.5
heart failure : Chapter VII.1
heart murmur : Chapter VII.2
heart rate : Chapter XIV.2
hectic fever : Chapter VI.3
Heimlich maneuver : Chapter VIII.6
Heiner's syndrome : Chapter VIII.7
Helicobacter pylori : Chapter IX.10
hemangioma : Chapter XXI.3
hematemesis : Chapter IX.10
hematochezia : Chapter IX.10
hematochezia : Chapter IX.11
hematochezia : Chapter IX.13
hematochezia : Chapter X.4
hematocrit : Chapter XI.1
hematogenous seeding : Chapter XIX.4
hematopoietic stem cell transplantation : Chapter V.6
hematuria : Chapter VII.5
hematuria : Chapter XIII.1
hemihypertrophy : Chapter XII.3
hemodialysis : Chapter XIII.4
hemoglobin : Chapter XI.1
hemoglobin A : Chapter XI.3
hemoglobin A1C : Chapter XV.1
hemoglobin Barts : Chapter XI.2
hemoglobin C : Chapter XI.3
hemoglobin constant springs : Chapter XI.2
hemoglobin constant springs : Chapter XI.3
hemoglobin E : Chapter XI.2
hemoglobin electrophoresis : Chapter XI.3
hemoglobin F : Chapter XI.3
hemoglobin H : Chapter XI.2
hemoglobin H disease : Chapter XI.2
hemoglobin S : Chapter XI.3
hemoglobin SC disease : Chapter XI.3
hemoglobin SS disease : Chapter XI.3
hemoglobinopathy : Chapter XI.1
hemoglobinopathy : Chapter XI.2
hemoglobinopathy : Chapter XI.3
hemoglobinuria : Chapter XI.7
hemolysis : Chapter III.2
hemolysis : Chapter XI.1
hemolytic anemia : Chapter XI.3
hemolytic transfusion reaction : Chapter XI.7
hemolytic uremic syndrome : Chapter VI.2
hemolytic uremic syndrome : Chapter XIII.5
hemolytic uremic syndrome (HUS) : Chapter IX.3
hemolytic uremic syndrome (HUS) : Chapter XI.6
hemophilia A : Chapter XI.6
hemophilia B : Chapter XI.6
hemoptysis : Chapter VIII.6
hemorrhagic disease of the newborn : Chapter II.6
hemorrhagic disease of the newborn : Chapter XI.5
hemorrhagic disease of the newborn : Chapter XI.6
hemorrhagic fever : Chapter VI.15
hemorrhagic shock : Chapter XIV.8
hemosiderin : Chapter VIII.7
hemosiderosis : Chapter VIII.7
Henderson-Hasselbalch equation : Chapter VIII.1
Henoch-Schonlein purpura : Chapter IX.2
Henoch-Schonlein purpura : Chapter IX.10
Henoch-Schonlein purpura : Chapter X.4
Henoch-Schonlein purpura : Chapter XIII.1
Henoch-Schonlein purpura : Chapter XIII.10
Henoch-Schonlein Purpura : Chapter XVI.3
hepadnavirus : Chapter VI.1
heparin induced thrombocytopenia : Chapter XI.6
hepatic amebiasis : Chapter IX.3
hepatic cirrhosis : Chapter VIII.3
hepatitis : Chapter IX.5
hepatitis : Chapter XI.7
hepatitis : Chapter XX.2
hepatitis A : Chapter IX.5
hepatitis A vaccine : Chapter I.4
hepatitis B : Chapter III.1
hepatitis B : Chapter III.11
hepatitis B : Chapter IX.5
hepatitis B immune globulin : Chapter III.11
hepatitis B prophylaxis : Chapter III.11
hepatitis B vaccine : Chapter I.4
hepatitis B vaccine : Chapter III.11
hepatitis C : Chapter IX.5
hepatitis D : Chapter IX.5
hepatitis vaccine : Chapter IX.5
hepatitis virus : Chapter VI.1
hepatocellular carcinoma : Chapter IX.5
hepatocellular necrosis : Chapter XIV.10
hepatosplenic cat scratch disease : Chapter VI.29
herd immunity : Chapter VI.10
hereditary angioedema : Chapter V.2
hereditary spherocytosis : Chapter XI.1
hereditary spherocytosis : Chapter XI.5
hermaphrodite : Chapter XIII.11
hernia : Chapter X.2
hernia : Chapter XIII.12
herniation : Chapter XVIII.13
heroin : Chapter XX.3
herpangina : Chapter VI.9
herpes encephalitis : Chapter III.11
Herpes simplex : Chapter III.10
herpes simplex : Chapter VI.1
herpes simplex : Chapter VI.15
herpes simplex : Chapter XVII.1
herpes simplex : Chapter XVII.4
herpes simplex virus (HSV) : Chapter III.11
herpes simplex virus (HSV) : Chapter VI.21
herpes virus : Chapter VI.9
herpesvirus : Chapter VI.1
heterochromia : Chapter XII.3
heterophile antibody : Chapter VI.23
heterotopia : Chapter XVIII.16
Hib : Chapter VI.13
high frequency ventilation : Chapter XIV.3
high frequency ventilation : Chapter XIV.5
high output congestive heart failure : Chapter XVIII.19
high-resolution computed tomography scan : Chapter VIII.5
hip avascular necrosis : Chapter XIX.6
hip dysplasia : Chapter XIX.6
hip pain : Chapter XIX.6
Hirschberg test : Chapter XVII.3
Hirschsprung's disease : Chapter IX.8
Hirschsprung's disease : Chapter IX.9
histamine-2 blockers : Chapter IX.6
histiocytosis-X : Chapter XXI.1
HIV : Chapter III.11
HIV : Chapter VI.1
HIV : Chapter VI.9
HIV : Chapter VI.20
HIV : Chapter VI.21
HIV : Chapter XI.6
HIV : Chapter XI.7
HIV : Chapter XX.2
HIV : Chapter XX.7
hives : Chapter V.2
hives : Chapter V.3
HIV-wasting : Chapter VI.20
HLA histocompatibility : Chapter V.6
Hodgkin's disease : Chapter XII.2
hollow viscus pain : Chapter IX.2
homatropine : Chapter XVII.5
homicide : Chapter XX.4
homocystinuria : Chapter IV.5
homosexuality : Chapter XX.6
hookworm : Chapter VI.31
hordeolum : Chapter XVII.4
HPA (hypothalamic pituitary axis) : Chapter V.4
human chorionic gonadotropin : Chapter IV.1
human diploid cell vaccine (HDCV) : Chapter VI.25
human herpes virus : Chapter VI.15
human herpes virus : Chapter VI.22
human herpes virus : Chapter VI.23
human immunodeficiency virus : Chapter VI.1
human milk : Chapter II.3
human papilloma virus (HPV) : Chapter XXI.6
human papillomavirus (HPV) : Chapter VI.21
human parvovirus : Chapter VI.22
human parvovirus : Chapter XI.3
human parvovirus : Chapter XI.4
human parvovirus B19 : Chapter III.11
human T-cell lymphotrophic virus : Chapter VI.1
Humate-P : Chapter XI.6
HUS : Chapter XIII.5
hyaline membrane disease : Chapter III.6
hydration : Chapter XI.3
hydration assessment : Chapter II.4
hydrocarbons : Chapter XIV.9
hydrocele : Chapter X.2
hydrocephalus : Chapter III.11
hydrocephalus : Chapter XVIII.9
hydrocephalus : Chapter XVIII.10
hydrocephalus : Chapter XVIII.16
hydrocortisone : Chapter V.4
hydrocortisone : Chapter XV.4
hydrocortisone : Chapter XXI.1
hydrocortisone : Chapter XXI.6
hydromorphone : Chapter XI.3
hydronephrosis : Chapter XIII.6
hydronephrosis : Chapter XIII.7
hydrops fetalis : Chapter VI.1
hydrops fetalis : Chapter XI.2
hydrops fetalis : Chapter XI.5
hydroxyapatite : Chapter I.12
hydroxyurea : Chapter XI.3
hydroxyzine : Chapter XXI.1
hygiene hypothesis : Chapter V.1
hymenoptera : Chapter XXI.5
hyper IgE syndrome : Chapter XXI.1
hyperactivity : Chapter I.10
hyperammonemia : Chapter IV.4
hyperammonemia : Chapter XVIII.17
hyperbilirubinemia : Chapter III.1
hyperbilirubinemia : Chapter III.2
hyperbilirubinemia : Chapter III.5
hypercalcemia : Chapter XV.6
hypercapnia : Chapter VIII.4
hypercarbia : Chapter XIV.3
hypercholesterolemia : Chapter XIII.2
hyperdontia : Chapter I.12
hyperglycemia : Chapter XV.1
hyperglycemia : Chapter XV.4
hyper-IgE syndrome : Chapter V.5
hyper-IgM syndrome : Chapter V.5
hyperimmune process : Chapter VIII.3
hyperinflation : Chapter VIII.6
hyperinsulinism : Chapter III.8
hyperkalemia : Chapter XIV.1
hyperkalemia : Chapter XV.4
hyperkeratosis : Chapter XXI.2
hyperkinetic disorder : Chapter I.10
hyperlipidemia : Chapter XIII.2
hypermagnesemia : Chapter XV.6
hypermenorrhea : Chapter XX.7
hypernatremia : Chapter XIV.6
hyperosmolar non-ketotic state : Chapter XV.1
hyperoxy test : Chapter III.7
hyperoxy test : Chapter VII.3
hyperparathyroidism : Chapter XV.6
hyperphosphatemia : Chapter XV.6
hyperreflexia : Chapter XVIII.2
hypersensitivity vasculitis : Chapter XVI.3
hypertension : Chapter XIII.1
hypertensive encephalopathy : Chapter XIII.1
hyperthyroidism : Chapter XV.2
hyperthyroidism : Chapter XVIII.15
hypertonic saline : Chapter XIV.2
hyperventilation : Chapter VIII.1
hyperventilation : Chapter XVIII.13
hyperviscosity : Chapter III.8
hyphema : Chapter XVII.5
hyphema : Chapter XIX.8
hypnozoite : Chapter VI.30
hypoalbuminemia : Chapter XIII.2
hypoallergenic formula : Chapter II.3
hypocalcemia : Chapter III.9
hypocalcemia : Chapter XIII.4
hypocalcemia : Chapter XV.6
hypocalcemia : Chapter XVIII.4
hypodontia : Chapter I.12
hypogammaglobulinemia : Chapter V.5
hypogenetic lung syndrome : Chapter VIII.8
hypoglossal nerve (CN XII) : Chapter XVIII.1
hypoglycemia : Chapter III.5
hypoglycemia : Chapter III.8
hypoglycemia : Chapter III.9
hypoglycemia : Chapter III.10
hypoglycemia : Chapter IV.4
hypoglycemia : Chapter XIV.1
hypoglycemia : Chapter XIV.9
hypoglycemia : Chapter XV.1
hypoglycemia : Chapter XV.4
hypoglycemia : Chapter XVIII.4
hypoglycemia : Chapter XVIII.17
hypokalemia : Chapter XIV.1
hypomagnesemia : Chapter III.9
hypomagnesemia : Chapter XV.6
hypomelanosis of Ito : Chapter XVIII.12
hyponatremia : Chapter III.9
hyponatremia : Chapter X.8
hyponatremia : Chapter XIV.6
hyponatremia : Chapter XV.4
hyponatremia : Chapter XVIII.4
hypopituitarism : Chapter XV.3
hypoplastic left heart : Chapter VII.3
hypoplastic lungs : Chapter III.6
hypoplastic lungs : Chapter XIII.3
hypoplastic right heart : Chapter VII.3
hypoproteinemia : Chapter XIII.2
hypospadias : Chapter XIII.12
hypotension : Chapter V.2
hypotension : Chapter XIV.2
hypotension : Chapter XIV.8
hypothalamic pituitary axis (HPA) : Chapter V.4
hypothermia : Chapter III.8
hypothermia : Chapter XIV.1
hypothermia : Chapter XV.4
hypothyroidism : Chapter III.1
hypothyroidism : Chapter XI.1
hypothyroidism : Chapter XV.2
hypothyroidism : Chapter XV.3
hypothyroidism : Chapter XVIII.15
hypovolemia : Chapter III.3
hypovolemia : Chapter XIV.1
hypovolemic shock : Chapter XIV.8
hypoxemia : Chapter XIV.1
hypoxemia : Chapter XIV.3
hypoxia : Chapter III.7
hypoxia : Chapter VIII.1
hypoxic ischemic brain injury : Chapter III.9
hypoxic ischemic encephalopathy : Chapter III.9
hypoxic-ischemic encephalopathy : Chapter XVIII.2
hypsarrhythmia : Chapter XVIII.4
hypsarrhythmia : Chapter XVIII.12
i-antigen : Chapter XI.4
iatrogenic adrenal insufficiency : Chapter XV.4
ibuprofen : Chapter VI.3
ICD codes : Chapter I.11
icosahedral head : Chapter VI.1
icteric leptospirosis : Chapter VI.28
icterus : Chapter IX.5
idiopathic childhood nephrosis : Chapter XIII.2
idiopathic thrombocytopenic purpura (ITP) : Chapter XI.6
IgA : Chapter II.2
IgA deficiency : Chapter V.5
IgA nephropathy : Chapter XIII.1
IgE : Chapter V.3
IL (interleukin) : Chapter VI.16
ileal atresia : Chapter X.9
imidazole : Chapter VI.32
imipenem : Chapter VI.5
imipramine : Chapter I.10
imipramine : Chapter XIII.9
immediate phase : Chapter VIII.2
immune deficiency : Chapter II.6
immune deficiency : Chapter V.5
immune thrombocytopenic purpura : Chapter XI.6
immunizations : Chapter III.5
immunizations : Chapter XII.2
immunodeficiency : Chapter VI.20
immunoglobulin : Chapter IX.5
immunophenotyping : Chapter XII.2
immunosuppression : Chapter XII.1
immunotherapy : Chapter V.1
impaction fracture : Chapter XIX.1
impetigo : Chapter VI.2
IMV (intermittent mandatory ventilation) : Chapter XIV.5
inactivated polio vaccine : Chapter I.4
inborn errors of metabolism : Chapter III.9
inborn errors of metabolism : Chapter IV.4
incarcerated inguinal hernia : Chapter X.2
incidence : Chapter XXII.3
incisor : Chapter I.12
incontinentia pigmenti : Chapter XVIII.12
indirect bilirubin : Chapter III.2
individualized education plans (IEP) : Chapter I.8
individualized family service plans (IFSP) : Chapter I.8
Individuals with Disabilities Education Act (IDEA) : Chapter I.8
indomethacin : Chapter III.4
infant botulism : Chapter XIV.3
infant botulism : Chapter XVIII.6
infant formula : Chapter II.1
infant mortality : Chapter III.5
infant mortality rate : Chapter XXII.3
infant of diabetic mother : Chapter III.8
infantile spasms : Chapter XVIII.4
infantile spasms : Chapter XVIII.12
infectious endocarditis : Chapter VII.5
infectious mononucleosis : Chapter VI.1
infectious mononucleosis : Chapter VI.9
infectious mononucleosis : Chapter VI.22
infectious mononucleosis : Chapter VI.23
inferential statistics : Chapter XXII.1
infertility : Chapter XII.1
inflammatory bowel disease : Chapter IX.2
inflammatory bowel disease : Chapter IX.10
inflammatory bowel disease : Chapter IX.11
inflammatory phase : Chapter VIII.2
influenza : Chapter VI.1
influenza : Chapter XVIII.17
influenza vaccine : Chapter I.4
influenza virus : Chapter VI.12
infusion : Chapter II.4
inguinal hernia : Chapter X.2
inguinal hernia : Chapter XIII.12
INH : Chapter VI.19
INH : Chapter XVIII.5
inhalants : Chapter XX.3
inhibin : Chapter IV.1
injury prevention : Chapter I.6
inotropes : Chapter VI.16
insect bites/stings : Chapter XXI.5
inspiratory pressure : Chapter XIV.5
inspiratory time (IT) : Chapter XIV.5
insulin : Chapter XV.1
insulin : Chapter XV.4
intention to treat analysis : Chapter XXII.2
interferon : Chapter XVIII.8
interferon gamma : Chapter VI.3
interleukin-1 : Chapter VI.3
intermittent fever : Chapter VI.3
internal fixation : Chapter XIX.1
intersex : Chapter XIII.11
intersex : Chapter XIII.12
interstitial emphysema : Chapter XIV.7
intestinal aganglionosis : Chapter IX.9
intestinal duplication : Chapter X.9
intraabdominal abscess : Chapter X.11
intracellular fluid (ICF) : Chapter II.4
intracerebral hemorrhage : Chapter XVIII.13
intracranial calcification : Chapter III.11
intracranial hemorrhage : Chapter III.9
intracranial hemorrhage : Chapter XVIII.2
intracranial hemorrhage : Chapter XVIII.19
intracranial pressure : Chapter XVIII.13
intractable crying : Chapter IX.1
intradermal nevi : Chapter XXI.3
intrahepatic air : Chapter III.12
intrahepatic biliary atresia : Chapter IX.4
intranasal corticosteroid : Chapter V.1
intraoperative cholangiogram : Chapter IX.4
intraosseous infusion : Chapter XIV.2
intraosseous infusion : Chapter XIV.8
intraportal air : Chapter III.12
intrauterine growth retardation (IUGR) : Chapter I.2
intrauterine growth retardation (IUGR) : Chapter III.4
intrauterine growth retardation (IUGR) : Chapter III.8
intrauterine growth retardation (IUGR) : Chapter XV.3
intravaginal torsion : Chapter XIII.10
intravenous fluid (IV) : Chapter II.4
intraventricular hemorrhage : Chapter III.5
intraventricular hemorrhage : Chapter XVIII.9
intubation : Chapter XIV.3
intubation : Chapter XIV.4
intubation : Chapter XVIII.5
intussusception : Chapter IX.2
intussusception : Chapter IX.10
intussusception : Chapter IX.13
intussusception : Chapter X.4
intussusception : Chapter XVI.3
intussusceptum : Chapter X.4
intussuscipiens : Chapter X.4
inversion : Chapter IV.7
involucrum : Chapter XIX.4
ipecac : Chapter XIV.9
ipecac : Chapter XIV.10
ipratropium : Chapter VIII.2
IPV : Chapter VI.24
iridocyclitis : Chapter XVI.2
iron : Chapter II.3
iron : Chapter XIV.9
iron binding capacity : Chapter XIV.11
iron chelation : Chapter XI.3
iron deficiency : Chapter XI.1
iron overdose : Chapter XIV.11
iron overload : Chapter XI.2
iron overload : Chapter XI.3
iron toxicity : Chapter XIV.11
irritant dermatitis : Chapter XXI.6
isoniazid : Chapter XVIII.5
isoproterenol : Chapter XIV.2
isotretinoin : Chapter IV.2
isotretinoin : Chapter XXI.2
IT ratio : Chapter III.10
ITP : Chapter XI.6
itraconazole : Chapter VI.32
IUGR : Chapter I.2
IUGR : Chapter III.8
IV gamma globulin : Chapter VI.17
IV gamma globulin : Chapter XVIII.7
IV rehydration : Chapter II.4
IV rehydration : Chapter IX.3
Ixodes pacificus : Chapter VI.27
Ixodes ricinus : Chapter VI.27
Ixodes scapularis : Chapter VI.27
Jacksonian march : Chapter XVIII.4
Janeway lesions : Chapter VII.5
Japanese encephalitis : Chapter VI.15
Jarisch-Herxheimer reaction : Chapter VI.21
jaundice : Chapter III.1
jaundice : Chapter III.2
jaundice : Chapter III.5
jaundice : Chapter IX.5
jaw thrust : Chapter XIV.1
JC virus : Chapter VI.1
jejunal atresia : Chapter X.9
Job's syndrome : Chapter XXI.1
Jones criteria : Chapter VII.4
JRA : Chapter XIX.6
junctional nevi : Chapter XXI.3
juvenile dermatomyositis : Chapter XVIII.15
juvenile polyps : Chapter IX.10
juvenile rheumatoid arthritis (JRA) : Chapter XVI.2
juvenile rheumatoid arthritis (JRA) : Chapter XIX.6
kala-azar : Chapter VI.31
karyotyping : Chapter IV.1
Kasabach-Merritt syndrome : Chapter XI.6
Kasabach-Merritt syndrome : Chapter XVIII.19
Kasai procedure : Chapter IX.4
Kawasaki disease : Chapter VI.17
Kawasaki disease : Chapter VI.18
Kawasaki disease : Chapter VI.22
Kawasaki disease : Chapter VI.34
Kayexalate : Chapter XV.4
keratoconjunctivitis : Chapter V.1
kerion : Chapter VI.32
kernicterus : Chapter III.2
ketoconazole : Chapter VI.32
ketosis : Chapter III.8
Klebsiella : Chapter VI.2
Klinefelter syndrome : Chapter IV.3
knee pain : Chapter XIX.6
Koch's postulates : Chapter XXII.3
KOH prep : Chapter VI.32
Koplik's spots : Chapter VI.22
Kostmann's syndrome : Chapter V.5
kwashiorkor : Chapter II.6
La Cross virus : Chapter VI.15
lacerations : Chapter X.1
lactase : Chapter II.3
lactase deficiency : Chapter II.3
lactated Ringer's : Chapter II.4
lactic acidosis : Chapter II.4
lactic acidosis : Chapter X.8
Lactobacillus : Chapter VI.2
lactose : Chapter II.2
lactose : Chapter II.3
lactose intolerance : Chapter II.3
Ladd's bands : Chapter X.5
Lancefield classification : Chapter VI.2
Landau reflex : Chapter XVIII.1
language delay : Chapter I.9
language disorder : Chapter I.9
lanugo : Chapter XX.5
laryngitis : Chapter VI.9
laryngitis : Chapter IX.6
laryngomalacia : Chapter VII.7
laryngomalacia : Chapter VIII.10
laryngomalacia : Chapter XIV.3
laryngoscope : Chapter XIV.4
laryngoscopy : Chapter VIII.10
laryngospasm : Chapter V.2
laryngotracheobronchitis : Chapter VI.12
latch-on : Chapter II.2
late phase inflammatory response : Chapter VIII.2
latent syphilis : Chapter VI.21
lateral collateral ligament injury : Chapter XIX.7
lateral condyle fracture : Chapter XIX.1
latex allergy : Chapter XVIII.10
latex-fruit syndrome : Chapter V.3
lavage : Chapter XIV.9
laxative : Chapter IX.8
laxative : Chapter XII.4
LCR : Chapter VI.21
LE cell : Chapter XVI.1
lead poisoning : Chapter XI.1
learning disability : Chapter I.8
learning disability : Chapter I.10
learning disability : Chapter XVIII.11
Leber's stellate neuroretinitis : Chapter VI.29
leg cramps : Chapter VIII.11
Legg-Calve-Perthes disease : Chapter XIX.6
Legg-Perthes disease : Chapter XIX.6
leishmaniasis : Chapter VI.31
Lennox-Gastaut : Chapter XVIII.4
lens : Chapter XVII.2
lentigines : Chapter XXI.3
leptomeningeal cyst : Chapter XVIII.13
leptospirosis : Chapter VI.28
lethargy : Chapter III.10
lethargy : Chapter X.4
leukemia : Chapter XI.4
leukemia : Chapter XII.2
leukemoid reaction : Chapter XI.5
leukocoria : Chapter XII.3
leukocoria : Chapter XVII.2
leukocyte adhesion defect : Chapter XI.8
leukocyte adhesion defect (LAD) : Chapter V.5
leukocytosis : Chapter VI.10
leukoencephalopathy : Chapter XII.1
leukopenia : Chapter XI.4
leukopenia : Chapter XVI.1
leukotriene inhibitor : Chapter V.1
leukotriene receptor antagonists : Chapter VIII.2
levofloxacin : Chapter VI.5
LGA infant : Chapter III.8
lice : Chapter XXI.6
lichenification : Chapter XXI.1
ligand chain reaction (LCR) : Chapter XX.7
ligase chain reaction (LCR) : Chapter VI.21
likelihood ratio : Chapter XXII.2
limb actigraphy : Chapter VIII.11
Limb girdle muscular dystrophy : Chapter XVIII.14
limp : Chapter XIX.4
limp : Chapter XIX.6
linear nevus syndrome : Chapter XVIII.12
linear regression : Chapter XXII.1
lineoleic acid : Chapter II.3
lipomeningocele : Chapter XVIII.10
Lisch nodules : Chapter XVIII.11
lissencephaly : Chapter XVIII.16
Listeria : Chapter III.10
Listeria : Chapter VI.2
Listeria monocytogenes : Chapter VI.2
lithium : Chapter IV.2
lithium : Chapter XIV.9
Little League elbow : Chapter XIX.8
liver abscess : Chapter X.11
liver failure : Chapter XIV.10
liver function tests (LFT) : Chapter IX.5
Loa loa : Chapter VI.31
local anesthesia : Chapter X.1
long arm posterior splint : Chapter XIX.2
longitudinal : Chapter XXII.3
lorazepam : Chapter III.9
lorazepam : Chapter XVIII.5
low birth weight : Chapter III.8
lower esophageal sphincter : Chapter IX.6
lower GI bleeding : Chapter IX.10
LSD : Chapter XX.3
lumbar puncture : Chapter III.10
lumbar puncture : Chapter VI.14
lumbar puncture : Chapter XVIII.3
Lunelle : Chapter XX.7
lung abscess : Chapter VIII.6
lung abscess : Chapter X.11
lupus : Chapter XVI.1
lupus anticoagulant : Chapter XI.6
lupus anticoagulant : Chapter XVI.1
lupus nephritis : Chapter XIII.1
Lyme disease : Chapter VI.27
lymphadenitis : Chapter VI.34
lymphadenitis : Chapter X.11
lymphadenopathy : Chapter VI.17
lymphadenopathy : Chapter VI.29
lymphadenopathy : Chapter VI.34
lymphangioma : Chapter X.12
lymphangioma circumscriptum : Chapter X.12
lymphangioma cystoides : Chapter X.12
lymphangioma simplex : Chapter X.12
lymphangiomyomatosis : Chapter XVIII.12
lymphangitis : Chapter VI.13
lymphangitis : Chapter VI.34
lymphatic abscess : Chapter X.11
lymphatic malformation : Chapter X.12
lymphocytosis : Chapter VI.10
lymphogranuloma venereum : Chapter VI.21
lymphoid interstitial pneumonitis : Chapter VI.20
lymphoma : Chapter XII.2
Lyonization : Chapter IV.7
lysergic acid diethylamide : Chapter XX.3
Macintosh blade : Chapter XIV.4
macrocephaly : Chapter XVIII.1
macrocephaly : Chapter XVIII.9
macrocytic : Chapter XI.1
macrodontia : Chapter I.12
macrolides : Chapter VI.5
macrosomia : Chapter III.4
macula : Chapter XVII.2
macule : Chapter XXI.6
Magill forceps : Chapter XIV.4
magnesium : Chapter XVIII.5
magnesium sulfate : Chapter III.4
maintenance electrolytes : Chapter II.4
maintenance fluids : Chapter II.4
malabsorption : Chapter VIII.3
malabsorption : Chapter IX.12
malar rash : Chapter XVI.1
malaria : Chapter VI.30
malaria : Chapter VI.31
malaria : Chapter XI.7
malaria prophylaxis : Chapter VI.30
Malassezia furfur : Chapter VI.32
Mallory-Weiss tear : Chapter IX.10
malnutrition : Chapter II.6
malnutrition : Chapter XIV.12
malrotation : Chapter X.5
managed care : Chapter I.11
mannitol : Chapter XVIII.13
mannitol : Chapter XVIII.17
MAP (mean airway pressure) : Chapter XIV.5
maple syrup urine disease (MSUD) : Chapter III.1
maple syrup urine disease (MSUD) : Chapter IV.4
marasmus : Chapter II.6
Marfan syndrome : Chapter IV.1
Marfan syndrome : Chapter IV.5
Marfan syndrome : Chapter VIII.5
marijuana : Chapter XX.3
marine envenomation : Chapter XXI.5
mask ventilation : Chapter III.3
mask ventilation : Chapter VI.12
mask ventilation : Chapter XIV.1
mastoidectomy : Chapter VI.8
mastoiditis : Chapter VI.6
mastoiditis : Chapter VI.8
maternal age : Chapter IV.1
maternal diabetes : Chapter III.4
maternal diabetes : Chapter III.8
maternal diabetes : Chapter IV.2
maternal epilepsy : Chapter IV.2
maternal hypertension : Chapter III.4
maternal infection : Chapter III.10
maternal pyrexia : Chapter IV.2
maternal substance abuse : Chapter III.4
maternal substance abuse : Chapter IV.2
maxillary sinus : Chapter VI.7
May-Hegglin anomaly : Chapter XI.6
MBC : Chapter VI.4
MBC : Chapter VII.5
McBurney's point : Chapter X.3
McCune Albright syndrome : Chapter XVIII.11
MCV : Chapter XI.1
MDI : Chapter VIII.2
meals : Chapter I.6
mean : Chapter XXII.1
mean airway pressure : Chapter XIV.5
measles : Chapter VI.1
measles : Chapter VI.15
measles : Chapter VI.22
measles vaccine : Chapter I.4
measles-mumps-rubella vaccine : Chapter I.4
meatitis : Chapter VI.17
mebendazole : Chapter VI.31
mechanical ventilation : Chapter XIV.5
Meckel's diverticulum : Chapter IX.10
Meckel's diverticulum : Chapter IX.13
Meckel's diverticulum : Chapter X.4
meconium : Chapter III.1
meconium aspiration : Chapter III.6
meconium aspiration : Chapter III.7
meconium ileus : Chapter VIII.3
meconium ileus : Chapter IX.8
meconium staining : Chapter III.10
meconium-stained amniotic fluid : Chapter III.3
medial collateral ligament injury : Chapter XIX.7
medical home : Chapter I.1
medical insurance : Chapter I.11
medical neglect : Chapter XIV.12
medulloblastoma : Chapter XVIII.18
mefloquine : Chapter VI.30
megalencephaly : Chapter XVIII.9
megaloblastic anemia : Chapter II.6
meibomian glands : Chapter XVII.4
melena : Chapter IX.10
melena : Chapter IX.13
membranoproliferative glomerulonephritis : Chapter XIII.1
membranoproliferative glomerulonephritis : Chapter XIII.2
membranoproliferative glomerulonephritis : Chapter XIII.5
membranous glomerulonephritis : Chapter XIII.2
menarche : Chapter XIX.3
menarche : Chapter XX.1
menarche : Chapter XX.7
Mendelian genetics : Chapter IV.7
meningitis : Chapter III.9
meningitis : Chapter VI.1
meningitis : Chapter VI.2
meningitis : Chapter VI.5
meningitis : Chapter VI.7
meningitis : Chapter VI.14
meningitis : Chapter VI.15
meningitis : Chapter VI.19
meningitis : Chapter XVIII.3
meningocele : Chapter XVIII.10
meningococcemia : Chapter VI.16
meningococcus : Chapter VI.2
meningomyelocele : Chapter IV.1
meningomyelocele : Chapter XVIII.10
meniscus injury : Chapter XIX.7
menometrorrhagia : Chapter XX.7
menorrhagia : Chapter XX.7
menstrual TSS : Chapter VI.18
menstruation : Chapter XX.7
mental retardation : Chapter I.8
mental retardation : Chapter XVIII.12
meperidine : Chapter XI.3
mercuric oxide : Chapter IX.7
mercury toxicity : Chapter IX.7
meropenem : Chapter VI.5
merozoites : Chapter VI.30
metabolic acidosis : Chapter II.4
metabolic acidosis : Chapter IV.4
metabolic acidosis : Chapter VIII.1
metabolic alkalosis : Chapter VIII.1
metabolic compensation : Chapter VIII.1
metalloporphyrins : Chapter III.2
metals : Chapter XIV.9
metaphysis : Chapter XIX.1
metaphysis : Chapter XIX.4
metered dose inhaler : Chapter VIII.2
methadone : Chapter XIV.9
methamphetamine : Chapter XX.3
methanol : Chapter XIV.9
methemoglobinemia : Chapter III.7
methemoglobinemia : Chapter VIII.1
methicillin : Chapter VI.2
methicillin : Chapter VI.5
methicillin resistant staph aureus : Chapter VI.2
methotrexate : Chapter XVI.1
methylphenidate : Chapter I.10
methylprednisolone : Chapter V.2
methylprednisolone : Chapter V.4
methylprednisolone : Chapter VIII.2
metronidazole : Chapter VI.5
metronidazole : Chapter VI.31
metronidazole : Chapter IX.11
metrorrhagia : Chapter XX.7
mezlocillin : Chapter VI.5
MHA-TP : Chapter VI.21
MIC : Chapter VI.4
MIC : Chapter VII.5
miconazole : Chapter VI.32
miconazole : Chapter XXI.6
microbiology : Chapter VI.2
microcephaly : Chapter XVIII.1
microcolon. : Chapter X.9
microcomedo : Chapter XXI.2
microcytic : Chapter XI.1
microdontia : Chapter I.12
microgyria : Chapter XVIII.16
Microsporidium : Chapter IX.3
Microsporum : Chapter VI.32
mid parental height : Chapter II.5
midazolam : Chapter XVIII.5
midgut volvulus : Chapter IX.10
midgut volvulus : Chapter X.5
mild intermittent asthma : Chapter VIII.2
mild persistent asthma : Chapter VIII.2
milk allergy : Chapter V.3
milk allergy : Chapter IX.10
milk protein sensitivity : Chapter IX.10
Miller blade : Chapter XIV.4
Miller-Dieker syndrome : Chapter XVIII.16
Miller-Fisher syndrome : Chapter XVIII.7
mineral oil : Chapter IX.8
mineralocorticoids : Chapter V.4
mineralocorticoids : Chapter XV.4
minimal brain dysfunction : Chapter I.10
minimal change disease : Chapter XIII.2
minimum bactericidal concentration : Chapter XIX.4
minimum bactericidal concentration : Chapter VI.4
minimum inhibitory concentration : Chapter VI.4
minimum inhibitory concentration : Chapter XIX.4
minocycline : Chapter VI.5
minute ventilation : Chapter VIII.1
minute ventilation : Chapter XIV.5
missense point mutation : Chapter IV.7
mitral insufficiency : Chapter VII.4
mittelschmerz : Chapter X.3
MMR vaccine : Chapter I.4
moderate persistent asthma : Chapter VIII.2
Mogen : Chapter XIII.8
molar : Chapter I.12
molding : Chapter III.1
molluscum contagiosum : Chapter VI.1
molluscum contagiosum : Chapter XXI.6
mometasone : Chapter VIII.2
monilial diaper rash : Chapter VI.32
monilial diaper rash : Chapter XXI.6
mononucleosis : Chapter VI.20
monosodium glutamate : Chapter V.3
Monospot : Chapter VI.9
Monospot : Chapter VI.23
Monteggia injury : Chapter XIX.1
montelukast : Chapter V.1
montelukast : Chapter VIII.2
mood disorders : Chapter XX.4
Moraxella : Chapter VI.2
Moraxella catarrhalis : Chapter VI.2
Moraxella catarrhalis : Chapter VI.7
morbilliform rash : Chapter VI.22
morning after contraception : Chapter XX.7
morning after pill : Chapter XX.7
Moro reflex : Chapter XVIII.1
morphine : Chapter XI.3
morphine : Chapter XIV.9
mortality rate : Chapter XXII.3
mosaicism : Chapter IV.7
mosquito vector : Chapter VI.15
MRI scan : Chapter XIX.4
MRSA : Chapter VI.2
MRSA : Chapter VI.5
mucocutaneous candidiasis : Chapter VI.32
mucocutaneous lymph node syndrome : Chapter VI.17
Mullerian duct : Chapter XIII.11
multicystic dysplastic kidney : Chapter XIII.3
multicystic kidney disease : Chapter XIII.3
multiple gestation : Chapter III.3
multiple gestation : Chapter III.4
multiple regression : Chapter XXII.1
multiple sclerosis : Chapter XVIII.8
multiple sleep latency test (MSLT) : Chapter VIII.11
mumps : Chapter VI.1
mumps : Chapter VI.15
mumps vaccine : Chapter I.4
Munchausen by proxy : Chapter XIV.12
muscle biopsy : Chapter XVIII.15
muscle relaxants : Chapter XIV.4
muscular dystrophy : Chapter XVIII.14
muscular dystrophy : Chapter XVIII.15
mutism : Chapter I.9
myasthenia gravis : Chapter XVIII.15
Mycobacterium : Chapter VI.2
Mycobacterium avium-intracellulare : Chapter VI.2
Mycobacterium leprae : Chapter VI.2
Mycobacterium marinum : Chapter VI.2
Mycobacterium tuberculosis : Chapter VI.2
Mycoplasma : Chapter VI.2
Mycoplasma : Chapter VI.5
Mycoplasma : Chapter VI.10
Mycoplasma : Chapter VI.11
Mycoplasma : Chapter VI.15
Mycostatin : Chapter VI.32
myelodysplasia : Chapter IV.1
myelodysplasia : Chapter XVIII.10
myelomeningocele : Chapter XVIII.10
Myeloperoxidase deficiency : Chapter V.5
myocardial infarction : Chapter VI.17
myocarditis : Chapter VI.1
myocarditis : Chapter VI.17
myocarditis : Chapter VII.1
myocarditis : Chapter VII.5
myocarditis : Chapter XVI.1
myonecrosis : Chapter VI.33
myopathy : Chapter XVIII.14
myopathy : Chapter XVIII.15
myositis : Chapter XVIII.15
Myotonic dystrophy : Chapter XVIII.14
myringotomy : Chapter VI.6
N-acetylcysteine : Chapter XIV.10
Naegleria fowleri : Chapter VI.31
nafcillin : Chapter VI.5
naked virus : Chapter VI.1
naloxone : Chapter XIV.3
naloxone : Chapter XIV.9
NAPQI : Chapter XIV.10
narcolepsy : Chapter VIII.11
narcotic overdose : Chapter XIV.3
narcotics : Chapter XIV.9
nasal CPAP : Chapter III.5
nasal CPAP : Chapter VIII.4
nasal lacrimal duct obstruction : Chapter XVII.2
nasopharyngitis : Chapter VI.9
nausea : Chapter XII.4
NCPAP : Chapter VIII.4
near drowning : Chapter XIV.6
nebulizer : Chapter VIII.2
NEC : Chapter III.5
NEC : Chapter III.12
Necator americanus : Chapter VI.31
necrotizing cellulitis : Chapter VI.33
necrotizing enterocolitis (NEC) : Chapter III.5
necrotizing enterocolitis (NEC) : Chapter III.12
necrotizing fasciitis : Chapter VI.2
necrotizing fasciitis : Chapter VI.13
necrotizing fasciitis : Chapter VI.33
nedocromil : Chapter VIII.2
negative predictive value : Chapter XXII.3
negative pressure ventilation : Chapter XIV.5
negative RNA virus : Chapter VI.1
Negri bodies : Chapter VI.25
Neisseria : Chapter VI.2
Neisseria gonorrhoeae : Chapter VI.2
Neisseria gonorrhoeae : Chapter VI.5
Neisseria gonorrhoeae : Chapter VI.21
Neisseria gonorrhoeae : Chapter XVII.1
Neisseria meningitidis : Chapter VI.2
Neisseria meningitidis : Chapter VI.16
nematodes (roundworm) : Chapter VI.31
neonatal cellulitis : Chapter VI.13
neonatal hepatitis : Chapter IX.4
neonatal herpes : Chapter III.11
neonatal jaundice : Chapter III.2
neonatal RDS : Chapter III.6
neonatal resuscitation : Chapter III.3
neonatal seizures : Chapter III.9
neonatal sepsis : Chapter III.10
nephritic syndrome : Chapter XIII.1
nephritic syndrome : Chapter XVI.3
nephritis : Chapter XIII.1
nephritis : Chapter XVI.1
nephrosis : Chapter XIII.2
nephrosis : Chapter XVI.1
nephrotic syndrome : Chapter XIII.2
nerve conduction studies : Chapter XVIII.7
nesidioblastosis : Chapter III.8
neural tube defects : Chapter IV.1
neural tube defects : Chapter IV.2
neural tube defects : Chapter XVIII.10
neural tube defects : Chapter XVIII.16
neuroblastoma : Chapter XII.3
neuroblastoma : Chapter XV.4
neurocutaneous stigmata : Chapter XVIII.1
neurocutaneous stigmata : Chapter XVIII.11
neurocutaneous stigmata : Chapter XVIII.12
neurocutaneous syndrome : Chapter XVIII.11
neurocutaneous syndrome : Chapter XVIII.12
neurocysticercosis : Chapter VI.31
neurofibromatosis : Chapter XVIII.11
neurofibromin : Chapter XVIII.11
neurogenic shock : Chapter XIV.8
neuroinvasive : Chapter VI.15
neurologic exam : Chapter XVIII.1
neuromuscular blockade : Chapter XVIII.6
neuromuscular junction : Chapter XVIII.6
neuronal migration defects : Chapter XVIII.16
neuropathy : Chapter XVIII.7
neuroretinitis : Chapter VI.29
neurosyphilis : Chapter VI.21
neurotropism : Chapter VI.15
neurovirulence : Chapter VI.15
neutropenia : Chapter XI.8
neutrophilia : Chapter XI.8
nevi : Chapter XXI.3
nevi : Chapter XXI.6
nevus : Chapter XXI.3
nevus : Chapter XXI.6
nevus flammeus : Chapter XXI.3
newborn care : Chapter III.1
newborn hearing screening : Chapter I.5
newborn resuscitation : Chapter III.3
newborn screening : Chapter III.1
newborn screening : Chapter IV.4
newborn screening : Chapter IV.6
newborn screening : Chapter XI.3
niacin : Chapter II.6
nicotine : Chapter XX.3
nicotinic acid : Chapter II.6
nightmares : Chapter VIII.11
NIH guidelines : Chapter VIII.2
nil disease : Chapter XIII.2
nitric oxide : Chapter III.7
nitric oxide : Chapter X.7
nitroblue tetrazolium (NBT) : Chapter V.5
nitroblue tetrazolium (NBT) : Chapter XI.8
nitrogen mustard : Chapter XII.1
nitroglycerine : Chapter XIV.2
nitroprusside : Chapter XIV.2
nocturia : Chapter XV.1
nocturnal leg cramps : Chapter VIII.11
nodular lymphoid hyperplasia : Chapter IX.10
nodule : Chapter XXI.6
non-A, non-B hepatitis : Chapter IX.5
non-communicating hydrocele : Chapter X.2
non-communicating hydrocephalus : Chapter XVIII.9
non-disjunction : Chapter IV.7
non-Hodgkin's lymphoma : Chapter XII.2
non-organic failure to thrive : Chapter II.5
nonsense point mutation : Chapter IV.7
Noonan syndrome : Chapter IV.3
norfloxacin : Chapter VI.5
normal distribution : Chapter XXII.1
normal saline (NS) : Chapter II.4
normocytic : Chapter XI.1
Norplant : Chapter XX.7
Norwalk virus : Chapter VI.1
Norwalk virus : Chapter IX.3
Norwood surgical procedure : Chapter VII.3
nuchal translucency : Chapter IV.1
nuclear scintigraphy : Chapter XIII.10
nucleic acid amplification test (NAAT) : Chapter VI.19
null hypothesis : Chapter XXII.1
number needed to treat : Chapter XXII.2
nursemaid's elbow : Chapter XIX.7
nursing bottle caries : Chapter I.12
nut allergy : Chapter V.3
nutrition : Chapter I.6
nutrition : Chapter II.1
nutritional insufficiency : Chapter I.2
nystagmus : Chapter XVII.2
nystatin : Chapter VI.32
nystatin : Chapter XXI.6
O negative PRBCs : Chapter XI.7
obesity : Chapter I.2
oblique fracture : Chapter XIX.1
obstructive sleep apnea : Chapter VIII.11
oculomotor nerve (CN III) : Chapter XVIII.1
olfactory nerve (CN I) : Chapter XVIII.1
oligoclonal bands : Chapter XVIII.8
oligohydramnios : Chapter III.3
oligohydramnios : Chapter III.4
oligomenorrhea : Chapter XX.7
omphalocele : Chapter X.6
omphalomesenteric duct : Chapter IX.13
Onchocerca volvulus : Chapter VI.31
ondansetron : Chapter XII.4
Ondine's curse : Chapter VIII.11
open fracture : Chapter XIX.1
open reduction : Chapter XIX.1
ophthalmia neonatorum : Chapter XVII.1
ophthalmic antibiotics : Chapter XVII.5
ophthalmitis : Chapter XVII.1
opiates : Chapter XIV.9
opiates : Chapter XX.3
opioids : Chapter XX.3
opportunistic infections : Chapter XII.1
oppositional defiant disorder : Chapter I.10
optic glioma : Chapter XVIII.11
optic nerve (CN II) : Chapter XVIII.1
optic neuritis : Chapter XVIII.8
Optochin : Chapter VI.2
optokinetic nystagmus : Chapter XVII.2
OPV : Chapter VI.24
oral allergy syndrome : Chapter V.3
oral challenge : Chapter V.3
oral contraceptives : Chapter XX.7
oral herpes : Chapter VI.1
oral intolerance : Chapter V.3
oral polio vaccine : Chapter I.4
oral rehydration : Chapter II.4
oral rehydration : Chapter IX.3
oral rehydration solution (ORS) : Chapter II.4
oral temperature : Chapter VI.3
orbital cellulitis : Chapter VI.13
orbital cellulitis : Chapter XVII.4
orbital fracture : Chapter XIX.8
orbivirus : Chapter VI.1
orchitis : Chapter XIII.10
organic acidemia : Chapter IV.4
organic failure to thrive : Chapter II.5
organophosphates : Chapter XIV.9
ORIF : Chapter XIX.1
ornithine transcarbamylase deficiency : Chapter IV.4
ORS (oral rehydration solution) : Chapter IX.3
orthomyxovirus : Chapter VI.1
orthophoria : Chapter XVII.3
orthostatic changes : Chapter IX.10
orthostatic hypotension : Chapter IX.10
Ortolani maneuver : Chapter XIX.6
oscillation ventilation : Chapter XIV.3
Osgood-Schlatter disease : Chapter XIX.8
Osler nodes : Chapter VII.5
osmolar gap : Chapter XIV.9
osmolarity : Chapter XIV.9
ossicles : Chapter VI.6
osteochondritis : Chapter XIX.8
osteochondritis dissecans : Chapter XIX.8
osteochondrosis : Chapter XIX.8
osteogenesis imperfecta : Chapter IV.1
osteogenesis imperfecta : Chapter IV.5
osteogenesis imperfecta : Chapter XVII.2
osteomyelitis : Chapter VI.2
osteomyelitis : Chapter VI.4
osteomyelitis : Chapter VI.5
osteomyelitis : Chapter VI.8
osteomyelitis : Chapter VI.13
osteomyelitis : Chapter XIX.4
osteomyelitis : Chapter XIX.6
osteosarcoma : Chapter XII.3
otitis externa : Chapter VI.6
otitis media : Chapter I.5
otitis media : Chapter VI.2
otitis media : Chapter VI.6
otitis media : Chapter VI.8
otitis media with effusion (OME) : Chapter VI.6
otorrhea : Chapter VI.6
ovarian torsion : Chapter IX.2
overdose : Chapter XIV.9
overriding fracture : Chapter XIX.1
oxacillin : Chapter VI.5
oximetry : Chapter VIII.1
oxitropium : Chapter VIII.2
oxygen : Chapter III.7
oxygen : Chapter VIII.4
oxygen : Chapter XIV.1
oxygen : Chapter XIV.3
oxygen content : Chapter VIII.1
oxygen delivery : Chapter VIII.1
oxygen hemoglobin dissociation curve : Chapter VIII.1
oxygen saturation : Chapter VIII.1
oxygen toxicity : Chapter III.5
oxytocin : Chapter II.2
pachygyria : Chapter XVIII.16
pacing : Chapter VII.6
pain : Chapter XII.4
pain crisis : Chapter XI.3
paint sniffing : Chapter XX.3
palivizumab : Chapter VI.11
palivizumab : Chapter VIII.4
palliative care : Chapter XII.4
pallor : Chapter VIII.1
Palmar grasp reflex : Chapter XVIII.1
pancreatic enzyme deficiency : Chapter VIII.3
pancreatitis : Chapter VIII.3
pancreatitis : Chapter IX.2
pancreatitis : Chapter IX.11
pancytopenia : Chapter XI.4
PANDAS : Chapter VI.9
panhypopituitarism : Chapter XV.3
Panner's disease : Chapter XIX.8
panophthalmitis : Chapter XVII.1
papillomavirus : Chapter VI.1
papovavirus : Chapter VI.1
papule : Chapter XXI.6
paracetamol : Chapter VI.3
Paragonimus : Chapter VI.31
parainfluenza virus : Chapter VI.1
parainfluenza virus : Chapter VI.9
parainfluenza virus : Chapter VI.12
paraldehyde : Chapter XVIII.5
paralysis : Chapter VI.24
paralyzing agents : Chapter XIV.4
paramyxovirus : Chapter VI.1
parasite : Chapter VI.31
parasomnia : Chapter VIII.11
parathyroid hormone (PTH) : Chapter XV.6
parenteral hyperalimentation : Chapter XII.1
parents' evaluation of developmental status (PEDS) : Chapter I.3
Parinaud's oculoglandular syndrome (POGS) : Chapter VI.29
Parkland formula : Chapter XXI.4
paronychia : Chapter XXI.6
parotitis : Chapter VI.9
paroxysmal cough : Chapter VI.10
paroxysmal nocturnal hemoglobinuria : Chapter XI.4
paroxysmal stage : Chapter VI.10
paroxysmal supraventricular tachycardia : Chapter XIV.1
partial anomalous pulmonary venous return : Chapter VIII.8
partial complex seizure : Chapter XVIII.4
partial complex status epilepticus : Chapter XVIII.5
partial seizure : Chapter XVIII.4
partial sepsis work-up : Chapter III.10
partial simple seizure : Chapter XVIII.4
partial thickness burn : Chapter XXI.4
partial thromboplastin time : Chapter XI.6
parvovirus : Chapter III.11
parvovirus : Chapter VI.1
parvovirus : Chapter VI.22
parvovirus : Chapter XI.4
PAS : Chapter VI.19
passive immunity : Chapter I.4
Pasteurella multocida : Chapter VI.13
Patau Syndrome : Chapter IV.3
patch : Chapter XXI.6
patella reflex : Chapter XVIII.1
patent ductus arteriosus : Chapter III.5
patent ductus arteriosus : Chapter VII.2
paternal age : Chapter IV.1
pathologic fracture : Chapter IV.5
patient controlled analgesia (PCA) : Chapter XI.3
patient controlled analgesia (PCA) : Chapter XII.4
pauci-articular JRA : Chapter XVI.2
Pavlik harness : Chapter XIX.6
pCO2 : Chapter VIII.1
pCO2 : Chapter XIV.5
PCP : Chapter XIV.9
PCP : Chapter XX.3
PCR : Chapter IV.6
PCR : Chapter VI.21
PDA : Chapter III.5
PDA : Chapter VII.2
PEA : Chapter XIV.1
peak flow : Chapter VIII.2
peanut allergy : Chapter V.3
pediculosis : Chapter XXI.6
PEDS : Chapter I.3
PEEP (positive end expiratory pressure) : Chapter VII.1
PEEP (positive end expiratory pressure) : Chapter XIV.3
PEEP (positive end expiratory pressure) : Chapter XIV.5
pellagra : Chapter II.6
pelvic inflammatory disease : Chapter VI.21
pemoline : Chapter I.10
penicillin : Chapter VI.18
penicillin prophylaxis : Chapter VII.4
penicillinase : Chapter VI.2
penicillinase : Chapter VI.5
penicillinase producing N. gonorrhoeae : Chapter VI.2
penicillinase resistant penicillins : Chapter VI.5
penis : Chapter XIII.12
pentobarbital : Chapter XVIII.5
peptic ulcer disease : Chapter IX.10
percutaneous umbilical blood sampling : Chapter IV.1
perennial allergic conjunctivitis : Chapter V.1
perennial allergic rhinitis : Chapter V.1
pericarditis : Chapter VII.5
perinatal CMV : Chapter III.11
perinatal drug abuse : Chapter XIV.12
perinatal encephalitis : Chapter VI.15
perinatal hepatitis : Chapter III.11
perinatal herpes : Chapter III.11
perinatal HIV : Chapter III.11
perinatal HIV : Chapter VI.20
perinatal HIV prophylaxis : Chapter III.11
perinatal infection : Chapter III.11
perinatal infection : Chapter VI.1
periorbital cellulitis : Chapter VI.7
periorbital cellulitis : Chapter VI.13
periorbital cellulitis : Chapter XVII.4
perirectal abscess : Chapter X.11
peritoneal dialysis : Chapter XIII.4
peritoneal pain : Chapter IX.2
peritonitis : Chapter VI.2
peritonitis : Chapter IX.2
peritonitis : Chapter X.3
peritonsillar abscess : Chapter VI.9
periventricular leukomalacia : Chapter III.5
permissive hypercapnia : Chapter VIII.2
pernicious anemia : Chapter II.6
persistent asthma : Chapter VIII.2
pertussis : Chapter VI.10
pertussis vaccine : Chapter I.4
pervasive developmental disorder : Chapter I.9
petechia : Chapter XVI.3
petechiae : Chapter VI.10
petit mal seizure : Chapter XVIII.4
petit mal status epilepticus : Chapter XVIII.5
pH : Chapter VIII.1
pH : Chapter XIV.5
phakomatoses : Chapter XVIII.11
phakomatoses : Chapter XVIII.12
pharyngitis : Chapter VI.2
pharyngitis : Chapter VI.9
phencyclidine : Chapter XX.3
phenobarbital : Chapter III.9
phenobarbital : Chapter XVIII.3
phenobarbital : Chapter XVIII.4
phenobarbital : Chapter XVIII.5
phenothiazine : Chapter XIV.9
phenylephrine : Chapter XIV.2
phenylketonuria (PKU) : Chapter III.1
phenylketonuria (PKU) : Chapter IV.4
phenytoin : Chapter III.9
phenytoin : Chapter XVIII.3
phenytoin : Chapter XVIII.4
phenytoin : Chapter XVIII.5
pheochromocytoma : Chapter XV.4
phimosis : Chapter III.1
phonological disorder : Chapter I.9
phosphodiesterase inhibitors : Chapter VII.1
photosensitivity : Chapter XVI.1
phototherapy : Chapter III.2
Phthirus pubis : Chapter VI.21
physiologic jaundice : Chapter III.1
physis : Chapter XIX.1
phytate : Chapter II.3
phytobezoar : Chapter IX.7
phytogens : Chapter II.3
Pickwickian syndrome : Chapter VIII.11
picornavirus : Chapter VI.1
PID (pelvic inflammatory disease) : Chapter VI.21
Pierre Robin sequence : Chapter X.10
Pierre-Robin syndrome : Chapter XIV.4
pilocarpine iontophoresis : Chapter VIII.3
pilonidal cyst : Chapter X.11
pine oil : Chapter XIV.9
pinworms : Chapter VI.31
PIP (peak inspiratory pressure) : Chapter XIV.5
piperacillin : Chapter VI.5
pitcher's elbow : Chapter XIX.8
pituitary : Chapter XVIII.18
Pityrosporum : Chapter VI.32
Pityrosporum ovale : Chapter XXI.2
placebo control : Chapter XXII.3
placenta previa. : Chapter III.3
plagiocephaly : Chapter X.10
plant alkaloids : Chapter XII.1
plantar reflex : Chapter XVIII.1
plants : Chapter XIV.9
plaque : Chapter XXI.6
plasma vial load (PVL) : Chapter VI.20
plasmapheresis : Chapter XVI.1
plasmapheresis : Chapter XVIII.7
Plasmodium : Chapter VI.30
Plasmodium : Chapter VI.31
Plasmodium falciparum : Chapter VI.30
Plasmodium malariae : Chapter VI.30
Plasmodium ovale : Chapter VI.30
Plasmodium vivax : Chapter VI.30
plaster : Chapter XIX.2
Plastibell : Chapter XIII.8
platelet aggregation : Chapter XI.6
platelet dysfunction : Chapter XIII.4
pleocytosis : Chapter VI.14
pneumatosis intestinalis : Chapter III.12
pneumococcal sepsis : Chapter XIII.2
pneumococcal vaccine : Chapter I.4
pneumococcal vaccine : Chapter VI.2
pneumococcal vaccine : Chapter XIII.2
pneumococcus : Chapter VI.2
pneumococcus : Chapter VI.7
pneumococcus : Chapter VI.11
pneumococcus : Chapter VI.16
Pneumocystis carinii pneumonia : Chapter VI.20
pneumomediastinum : Chapter III.6
pneumomediastinum : Chapter VI.10
pneumomediastinum : Chapter VIII.6
pneumomediastinum : Chapter XIV.7
pneumonia : Chapter III.6
pneumonia : Chapter VI.2
pneumonia : Chapter VI.10
pneumonia : Chapter VI.11
pneumonia : Chapter IX.2
pneumonia : Chapter XIV.3
pneumonia : Chapter XVII.1
pneumonitis : Chapter XVI.1
pneumopericardium : Chapter XIV.7
pneumoperitoneum : Chapter III.12
pneumoperitoneum : Chapter XIV.7
pneumothorax : Chapter III.6
pneumothorax : Chapter III.7
pneumothorax : Chapter VI.10
pneumothorax : Chapter VIII.3
pneumothorax : Chapter VIII.6
pneumothorax : Chapter X.7
pneumothorax : Chapter XIV.1
pneumothorax : Chapter XIV.3
pneumothorax : Chapter XIV.7
pO2 : Chapter VIII.1
pO2 : Chapter XIV.5
poison prevention : Chapter I.6
poisons : Chapter XIV.9
polio vaccine : Chapter I.4
poliomyelitis : Chapter VI.24
poliovirus : Chapter VI.1
poliovirus : Chapter VI.24
polyarteritis nodosa : Chapter XVI.3
polyarthritis : Chapter VII.4
polyarticular JRA : Chapter XVI.2
polycystic kidney disease : Chapter XIII.3
polycythemia : Chapter III.7
polycythemia : Chapter III.8
polydipsia : Chapter XV.1
polydipsia : Chapter XV.5
polyglandular failure syndrome : Chapter XV.4
polyhydramnios : Chapter III.3
polyhydramnios : Chapter III.4
polymenorrhea : Chapter XX.7
polymerase chain reaction : Chapter IV.6
polymerase chain reaction : Chapter VI.21
polymerase chain reaction (PCR) : Chapter XX.7
polymicrogyria : Chapter XVIII.16
polymorphonuclear leukocyte : Chapter XI.8
polymorphous rash : Chapter VI.17
polymyositis : Chapter XVIII.15
polyneuritis : Chapter XVIII.7
polyneuropathy : Chapter XVIII.7
polyomavirus : Chapter VI.1
polyphagia : Chapter XV.1
polyps : Chapter IX.10
polysaccharide capsule : Chapter VI.2
polysomnography (PSG) : Chapter VIII.11
polyuria : Chapter XV.1
polyuria : Chapter XV.5
port wine stain : Chapter XXI.3
portal air : Chapter III.12
portal hypertension : Chapter IX.10
portal venous gas (PVG) : Chapter III.12
Portuguese Man-O-War : Chapter XXI.5
positive predictive value : Chapter XXII.3
positive pressure ventilation : Chapter III.6
positive pressure ventilation : Chapter VII.1
positive pressure ventilator : Chapter XIV.7
positive RNA virus : Chapter VI.1
posterior urethral valves : Chapter XIII.7
post-hemorrhagic hydrocephalus : Chapter XVIII.9
post-infectious encephalitis : Chapter VI.15
post-polio syndrome : Chapter VI.24
post-streptococcal glomerulonephritis : Chapter XIII.1
posttest probability : Chapter XXII.2
potassium : Chapter II.4
potassium : Chapter XIV.9
potassium hydroxide preparation : Chapter VI.32
Potter syndrome : Chapter IV.2
Potter syndrome : Chapter XIII.3
Pott's puffy tumor : Chapter VI.7
potty training : Chapter I.6
povidone-iodine : Chapter XVII.1
poxvirus : Chapter VI.1
ppd : Chapter VI.19
PPNG : Chapter VI.2
PPNG : Chapter VI.5
Prader-Willi syndrome : Chapter VIII.11
pranlukast : Chapter VIII.2
praziquantel : Chapter VI.31
PRBC : Chapter XI.7
PRBC transfusion : Chapter XIV.2
PRBCs : Chapter XIV.8
prednisolone : Chapter V.4
prednisolone : Chapter VIII.2
prednisone : Chapter V.4
prednisone : Chapter VIII.2
preeclampsia : Chapter III.4
pregnancy : Chapter XX.7
pregnancy associated plasma protein-A : Chapter IV.1
Prehn's sign : Chapter XIII.10
pre-load : Chapter XIV.2
premature labor : Chapter III.4
prematurity : Chapter III.4
prematurity : Chapter III.5
prematurity : Chapter III.8
prematurity : Chapter III.10
prematurity : Chapter III.12
prematurity : Chapter VIII.4
prematurity : Chapter XVIII.2
premolar : Chapter I.12
prenatal care : Chapter III.10
prenatal screening : Chapter IV.1
prenatal testing : Chapter IV.1
prenatal ultrasound : Chapter X.6
pressure patch : Chapter XVII.5
pressure sores : Chapter XIX.2
pressure ventilation : Chapter XIV.5
preterm labor : Chapter III.4
pretest probability : Chapter XXII.2
prevalence : Chapter XXII.3
preventive medicine : Chapter I.6
primaquine : Chapter VI.30
primary care : Chapter I.1
primary intention : Chapter X.1
primary survey : Chapter XIV.8
primitive neuroectodermal tumor : Chapter XVIII.18
primitive reflexes : Chapter XVIII.1
progestin only pill : Chapter XX.7
projectile vomiting : Chapter X.8
prolactin : Chapter II.2
prolapsed cord : Chapter III.3
prolonged QT : Chapter VIII.12
prolonged QT syndrome : Chapter VII.6
prolonged rupture of membranes : Chapter III.4
prolonged rupture of membranes : Chapter III.10
pronator sign : Chapter XVIII.1
prone sleeping : Chapter VIII.12
proparacaine : Chapter XVII.5
prophylactic antibiotics : Chapter VI.5
Propionibacterium acnes : Chapter XXI.2
propofol : Chapter XVIII.5
proprioception : Chapter XVIII.1
prospective : Chapter XXII.3
prostaglandin E1 : Chapter VII.3
protease inhibitors : Chapter VI.20
protein : Chapter II.1
protein C : Chapter VI.16
protein hydrolysate formula : Chapter II.3
protein hydrolysate formula : Chapter IX.1
protein-energy malnutrition : Chapter II.6
proteinuria : Chapter XIII.2
Proteus : Chapter VI.2
prothrombin time : Chapter XI.6
protodyssomnia : Chapter VIII.11
protozoan : Chapter VI.31
provitamin D3 : Chapter II.6
Prune Belly Syndrome : Chapter XIII.7
pseudoesotropia : Chapter XVII.3
pseudohermaphrodite : Chapter XIII.11
pseudohypertrophy : Chapter XVIII.14
pseudohypoaldosteronism : Chapter XV.4
pseudohypoparathyroidism : Chapter XV.6
pseudoleukemia : Chapter XI.5
pseudomembranous colitis : Chapter VI.5
pseudomenses : Chapter III.1
Pseudomonas : Chapter VI.2
pseudomonas aeruginosa : Chapter VIII.3
pseudoparalysis : Chapter XIX.4
pseudostrabismus : Chapter XVII.3
PSVT : Chapter VII.6
psychogenic polydipsia : Chapter XV.5
psychogenic water drinking : Chapter XV.5
psychomotor epilepsy : Chapter XVIII.4
psychosis : Chapter XX.3
PT : Chapter XI.6
PTT : Chapter XI.6
PTT mixing study : Chapter XI.6
puberty : Chapter XX.1
pubic lice : Chapter VI.21
PUBS : Chapter IV.1
pulmocardiac resuscitation : Chapter XIV.1
pulmonary edema : Chapter VII.1
pulmonary hemorrhage : Chapter VIII.7
pulmonary hemosiderosis : Chapter VIII.7
pulmonary hypertension : Chapter III.6
pulmonary hypertension : Chapter III.7
pulmonary hypertension : Chapter VIII.8
pulmonary hypertension : Chapter X.7
pulmonary hypoplasia : Chapter III.6
pulmonary hypoplasia : Chapter III.7
pulmonary hypoplasia : Chapter X.7
pulmonary hypoplasia : Chapter XIII.3
pulmonary infarction : Chapter XI.3
pulmonary infection : Chapter VI.11
pulmonary sequestration : Chapter VIII.8
pulmonary sling : Chapter VII.7
pulmonary vascular syndrome : Chapter VIII.8
pulmonary venolobar syndrome : Chapter VIII.8
pulmonic atresia : Chapter VII.3
pulmonic insufficiency : Chapter VII.2
pulmonic stenosis : Chapter VII.2
pulse oximetry : Chapter VIII.1
pulse oximetry : Chapter VIII.4
pulseless electrical activity (PEA) : Chapter XIV.1
punctate keratopathy : Chapter XVII.5
puncture wounds : Chapter X.1
punishment : Chapter I.6
punishment : Chapter I.7
pupillary light reflex : Chapter XVII.2
purging : Chapter XX.5
purpura : Chapter XVI.3
pustule : Chapter XXI.6
PUVA : Chapter XXI.1
pyelonephritis : Chapter XIII.6
pyloric stenosis : Chapter IX.6
pyloric stenosis : Chapter X.8
pyloric stenosis : Chapter XVII.1
pyloromyotomy : Chapter X.8
pyoderma gangrenosum : Chapter IX.11
pyomyositis : Chapter X.11
pyramidal tract : Chapter XVIII.1
pyrantel pamoate : Chapter VI.31
pyrazinamide : Chapter VI.19
pyridoxine : Chapter II.6
pyrogen : Chapter VI.3
pyuria : Chapter VI.17
pyuria : Chapter XIII.10
quadriceps reflex : Chapter XVIII.1
quantiferon : Chapter VI.19
quartan malaria : Chapter VI.30
quinolones : Chapter VI.5
rabies : Chapter VI.1
rabies : Chapter VI.15
rabies : Chapter VI.25
rabies immune globulin (RIG) : Chapter VI.25
racemic epinephrine : Chapter VI.12
RAD (reversible airway disease) : Chapter VIII.2
radial periosteal reflex : Chapter XVIII.1
radiation therapy : Chapter XII.1
radioallergosorbent test (RAST) : Chapter V.3
rapid eye movement (REM) : Chapter VIII.11
rapid sequence intubation : Chapter XIV.4
rapid sequence intubation : Chapter XVIII.5
Rashkind procedure : Chapter VII.3
RAST : Chapter V.1
RAST : Chapter V.3
Rastelli procedure : Chapter VII.3
Raynaud's phenomenon : Chapter XVI.1
RDS : Chapter III.6
RDS : Chapter III.7
RDW : Chapter XI.1
reactive airway disease : Chapter VIII.4
recessive inheritance : Chapter IV.4
rectal bleeding : Chapter IX.10
rectal prolapse : Chapter VIII.3
rectal swab : Chapter IX.3
rectal temperature : Chapter VI.3
recurrent infection : Chapter V.5
red reflex : Chapter XVII.2
reflux : Chapter IX.6
regional enteritis : Chapter IX.11
regional ileitis : Chapter IX.11
regression : Chapter XXII.1
rehydration : Chapter II.4
rehydration : Chapter IX.3
relapsing fever : Chapter VI.3
relative risk reduction : Chapter XXII.2
REM : Chapter VIII.11
remittent fever : Chapter VI.3
renal biopsy : Chapter XIII.2
renal cysts : Chapter XVIII.12
renal failure : Chapter XIII.2
renal failure : Chapter XIII.4
renal osteodystrophy : Chapter XIII.4
renal osteodystrophy : Chapter XV.6
renal scanning : Chapter XIII.7
renin : Chapter XV.4
reovirus : Chapter VI.1
replacement fluids : Chapter II.4
respiratory acidosis : Chapter VIII.1
respiratory alkalosis : Chapter VIII.1
respiratory arrest : Chapter XIV.1
respiratory compensation : Chapter VIII.1
respiratory distress : Chapter III.6
respiratory distress : Chapter III.7
respiratory distress syndrome (RDS) : Chapter III.5
respiratory failure : Chapter VI.12
respiratory failure : Chapter VIII.1
respiratory failure : Chapter XIV.1
respiratory failure : Chapter XIV.3
respiratory failure : Chapter XIV.4
respiratory failure : Chapter XVIII.6
respiratory failure : Chapter XVIII.7
respiratory syncytial virus (RSV) : Chapter VI.1
respiratory syncytial virus (RSV) : Chapter VI.11
respiratory syncytial virus (RSV) : Chapter VIII.4
respiratory syncytial virus (RSV) : Chapter XIV.3
reticulocyte count : Chapter XI.1
retinal hemorrhage : Chapter VI.10
retinal hemorrhages : Chapter XIV.12
retinoblastoma : Chapter XII.3
retinoblastoma : Chapter XVII.2
retinoic acid : Chapter II.6
retinol : Chapter II.6
retinopathy of prematurity : Chapter III.5
retropharyngeal abscess : Chapter VI.9
retropharyngeal abscess : Chapter VI.12
retrospective : Chapter XXII.3
retrovirus : Chapter VI.1
Rett's disorder : Chapter I.9
reverse transcriptase : Chapter VI.20
reverse transcriptase inhibitors : Chapter VI.20
rewarding : Chapter I.7
Reye syndrome : Chapter XVIII.17
Rh : Chapter XI.7
Rh incompatibility : Chapter III.2
Rh incompatibility : Chapter XI.5
rhabdovirus : Chapter VI.1
rhabdovirus : Chapter VI.25
rheumatic fever : Chapter VI.2
rheumatic fever : Chapter VI.9
rheumatic fever : Chapter VII.4
rheumatic fever : Chapter VII.5
rheumatic heart disease : Chapter VII.4
rheumatoid arthritis : Chapter XVI.2
rheumatoid factor : Chapter XVI.2
rhinitis : Chapter VI.9
rhinitis medicamentosa : Chapter V.1
rhinoconjunctivitis : Chapter V.1
rhinosinusitis : Chapter VI.7
rhinovirus : Chapter VI.1
rhinovirus : Chapter VI.9
rhythmic movements : Chapter VIII.11
riboflavin : Chapter II.6
rickets : Chapter II.1
rickets : Chapter XV.6
Rickettsia : Chapter VI.2
Rickettsia rickettsii : Chapter VI.26
rifampin : Chapter VI.19
right aortic arch : Chapter VII.7
right pulmonary artery syndrome : Chapter VIII.8
ring chromosome formation : Chapter IV.7
Risser stage : Chapter XIX.3
ristocetin cofactor : Chapter XI.6
RNA virus : Chapter VI.1
ROAD (reversible obstructive airway disease) : Chapter VIII.2
Robertsonian translocation : Chapter IV.7
Rocky Mountain Spotted Fever : Chapter VI.2
Rocky Mountain Spotted Fever : Chapter VI.26
Rolandic epilepsy : Chapter XVIII.4
Romberg test : Chapter XVIII.1
roseola infantum : Chapter VI.22
rotavirus : Chapter VI.1
rotavirus : Chapter IX.3
Roth spots : Chapter VII.5
RPR : Chapter VI.21
RPR : Chapter XVI.1
RSV : Chapter VI.1
RSV : Chapter VI.9
RSV : Chapter VIII.4
RSV : Chapter XIV.3
RSV immune globulin : Chapter VIII.4
RSV prophylaxis : Chapter III.5
rubella : Chapter III.11
rubella : Chapter VI.1
rubella : Chapter VI.15
rubella : Chapter VI.22
rubella vaccine : Chapter I.4
rubeola : Chapter VI.1
rubeola : Chapter VI.22
Russell-Silver syndrome : Chapter XVIII.11
Sabin vaccine : Chapter I.4
Sabin vaccine : Chapter VI.24
salbutamol : Chapter VIII.2
salicylates : Chapter VI.17
salicylates : Chapter XIV.9
salicylates : Chapter XVIII.17
saline : Chapter II.4
Salk vaccine : Chapter I.4
Salk vaccine : Chapter VI.24
salmeterol : Chapter VIII.2
salmon patch : Chapter XXI.3
Salmonella : Chapter IX.3
salpingitis : Chapter VI.21
salt wasting : Chapter XV.4
salt wasting crisis : Chapter XIII.11
Salter Harris type I fracture : Chapter XIX.2
Salter-Harris fracture : Chapter XIX.1
SBE prophylaxis : Chapter VII.5
SC disease : Chapter XI.3
scabies : Chapter XXI.6
scald burn : Chapter XXI.4
scales : Chapter XXI.6
scaphoid fracture : Chapter XIX.2
scarf sign : Chapter XVIII.1
scarlet fever : Chapter VI.2
scarlet fever : Chapter VI.18
scars : Chapter XXI.6
SCFE : Chapter XIX.6
Schilling test : Chapter IX.12
Schilling test : Chapter XI.1
schistosomiasis : Chapter VI.31
schizencephaly : Chapter XVIII.16
schizont : Chapter VI.30
Schlichter test : Chapter VI.4
school health : Chapter I.8
Schuffner dots : Chapter VI.30
schwannoma : Chapter XVIII.11
scimitar syndrome : Chapter VIII.8
sclera : Chapter XVII.2
sclerosing cholangitis : Chapter IX.11
scolding : Chapter I.7
scoliosis : Chapter IV.5
scoliosis : Chapter XVIII.2
scoliosis : Chapter XIX.3
scombroid poisoning : Chapter V.3
scorpion : Chapter XXI.5
screening : Chapter IV.1
scrotal exploration : Chapter XIII.10
scrotal hydrocele : Chapter X.2
scurvy : Chapter II.6
seafood allergy : Chapter V.3
seasonal allergic conjunctivitis : Chapter V.1
seasonal allergic rhinitis : Chapter V.1
seborrhea : Chapter XXI.1
second degree burns : Chapter XXI.4
secondary intention : Chapter X.1
secondary nephrotic syndrome : Chapter XIII.2
secondary pneumothorax : Chapter XIV.7
secondary survey : Chapter XIV.8
sed rate : Chapter XIX.4
sedatives : Chapter XIV.4
sedatives : Chapter XIV.9
sedatives : Chapter XX.3
seizure : Chapter VI.3
seizure : Chapter XVIII.3
seizure : Chapter XVIII.4
seizure disorder : Chapter IV.2
seizure disorder : Chapter XVIII.2
seizures : Chapter III.9
seizures : Chapter VI.10
seizures : Chapter VI.15
seizures : Chapter XIV.9
seizures : Chapter XVIII.5
seizures : Chapter XVIII.11
seizures : Chapter XVIII.12
seizures : Chapter XVIII.19
selective IgA deficiency : Chapter V.5
selective mutism : Chapter I.9
selenium sulfide : Chapter VI.32
sensitivity : Chapter XXII.3
sensorineural hearing loss : Chapter I.5
sensorineural hearing loss : Chapter VI.14
sepsis : Chapter III.8
sepsis : Chapter III.10
sepsis : Chapter IV.4
sepsis : Chapter VI.2
sepsis : Chapter VI.16
sepsis : Chapter XIII.2
sepsis : Chapter XV.4
sepsis work-up : Chapter III.10
septic arthritis : Chapter VI.2
septic arthritis : Chapter VI.4
septic arthritis : Chapter VI.13
septic arthritis : Chapter XIX.5
septic fever : Chapter VI.3
septic joint : Chapter XIX.6
septic shock : Chapter VI.16
sequestration : Chapter VIII.8
serositis : Chapter IX.2
serositis : Chapter XVI.1
serotonin : Chapter XX.3
Serratia : Chapter VI.2
serum iron : Chapter XI.1
serum sickness : Chapter V.2
serum sickness : Chapter VI.17
severe combined immune deficiency : Chapter V.5
severe persistent asthma : Chapter VIII.2
Sever's disease : Chapter XIX.8
sex abuse : Chapter VI.21
sex abuse : Chapter IX.8
sex abuse : Chapter XIV.12
sexual maturity rating : Chapter XX.1
sexual orientation : Chapter XX.6
sexuality : Chapter XX.6
sexually transmitted disease : Chapter VI.21
sexually transmitted disease : Chapter XX.7
SGA : Chapter I.2
SGA infant : Chapter III.8
shagreen patch : Chapter XVIII.12
shagreen patches : Chapter XVIII.1
shaken baby syndrome : Chapter XIV.12
shellfish allergy : Chapter V.3
shigatoxin : Chapter IX.3
shigatoxin : Chapter XIII.5
Shigella : Chapter IX.3
shingles : Chapter VI.1
shingles : Chapter VI.22
shingles : Chapter XXI.6
shock : Chapter XIV.2
shock : Chapter XIV.8
shock : Chapter XV.4
shock, anaphylaxis : Chapter XIV.2
shock, cardiogenic : Chapter XIV.2
shock, compensated : Chapter XIV.2
shock, distributive : Chapter XIV.2
shock, hypovolemic : Chapter XIV.2
shock, obstructive : Chapter XIV.2
shock, relative : Chapter XIV.2
shock, septic : Chapter XIV.2
shock, spinal cord injury : Chapter XIV.2
shock, uncompensated : Chapter XIV.2
short stature : Chapter XV.3
shoulder dislocation : Chapter XIX.7
shoulder reduction : Chapter XIX.7
Shwachman syndrome : Chapter V.5
Shwachman-Diamond syndrome : Chapter XI.8
SIADH : Chapter XV.5
sick sinus syndrome : Chapter VII.6
sickle beta thal : Chapter XI.3
sickle cell anemia : Chapter XI.1
sickle cell anemia : Chapter XI.3
sickle cell disease : Chapter III.1
sickle cell disease : Chapter IV.1
sickle cell disease : Chapter XI.3
sickle cell disease : Chapter XIX.4
sickle cell trait : Chapter XI.3
sideroblastic anemia : Chapter XI.1
SIDS : Chapter III.1
SIDS : Chapter VIII.12
SIDS : Chapter XIV.1
SIDS : Chapter XIV.12
sigmoid volvulus : Chapter X.5
silent asthma : Chapter VIII.2
silent carrier : Chapter XI.2
silo reduction : Chapter X.6
silver nitrate : Chapter XVII.1
silver sulfadiazine : Chapter XXI.4
simethicone : Chapter IX.1
SIMV (synchronized IMV) : Chapter XIV.5
single donor platelets : Chapter XI.7
sinus arrhythmia : Chapter VII.6
sinus headache : Chapter VI.7
sinusitis : Chapter VI.2
sinusitis : Chapter VI.7
sinusitis : Chapter VIII.3
sinusitis : Chapter XVII.4
SIRS : Chapter III.10
SIRS : Chapter VI.16
sixth's disease : Chapter VI.22
skeletal survey : Chapter XIV.12
skin prick testing : Chapter V.3
skin testing : Chapter V.1
skin testing : Chapter V.3
skin testing : Chapter VI.19
skip lesions : Chapter IX.11
skull fracture : Chapter XVIII.13
SLE : Chapter XI.6
SLE : Chapter XIII.1
SLE : Chapter XVI.1
sleep apnea : Chapter VIII.11
sleep bruxism : Chapter VIII.11
sleep disorders : Chapter VIII.11
sleep position : Chapter III.1
sleep talking : Chapter VIII.11
sleep terror : Chapter VIII.11
sleep walking : Chapter VIII.11
slipped capital femoral epiphysis : Chapter XIX.6
slit lamp : Chapter XVII.5
small for gestational age (SGA) : Chapter I.2
small for gestational age (SGA) : Chapter III.4
small for gestational age (SGA) : Chapter XV.3
smallpox : Chapter VI.1
smoke detectors : Chapter I.6
smoke inhalation : Chapter XXI.4
smoking cessation : Chapter I.6
snacks : Chapter I.6
snake bites : Chapter XIV.9
snow blindness : Chapter XVII.5
sodium : Chapter II.4
solvents : Chapter XX.3
soy formula : Chapter II.3
spanking : Chapter I.7
spasmodic croup : Chapter VI.12
spastic diplegia : Chapter XVIII.2
special education : Chapter I.8
special health care needs : Chapter I.8
specialty referral : Chapter I.1
specific antibiotics : Chapter VI.5
specificity : Chapter XXII.3
speech delay : Chapter I.9
speech delay : Chapter VI.6
spermatic cord : Chapter XIII.10
spermicide : Chapter XX.7
sphenoid sinus : Chapter VI.7
spider bites : Chapter XXI.5
spiking fever : Chapter VI.3
spina bifida : Chapter IV.1
spina bifida : Chapter XVIII.10
spina bifida occulta : Chapter XVIII.10
spinal accessory nerve (CN XI) : Chapter XVIII.1
spinal shock : Chapter XIV.8
spiral fracture : Chapter XIX.1
spirochetes : Chapter VI.2
spleen injury : Chapter XIV.8
splenic sequestration crisis : Chapter XI.3
splint : Chapter XIX.1
splint : Chapter XIX.2
splinter hemorrhage : Chapter VII.5
spondyloarthropathy : Chapter XVI.2
Spores, bacteria : Chapter VI.2
sporozoans : Chapter VI.31
sporozoite : Chapter VI.30
sports injuries : Chapter XIX.8
sprain : Chapter XIX.7
sputum : Chapter VI.19
SRY gene : Chapter XIII.11
SS disease : Chapter XI.3
St. Louis encephalitis : Chapter VI.1
St. Louis encephalitis : Chapter VI.15
staccato cough : Chapter XVII.1
Stachybotrys : Chapter VIII.7
standard deviation : Chapter XXII.1
Staph aureus : Chapter VI.2
Staph aureus : Chapter VI.5
Staph aureus : Chapter VI.11
Staph aureus : Chapter VI.13
Staph aureus : Chapter VI.16
Staph aureus : Chapter VI.18
Staph aureus : Chapter VI.34
Staph aureus : Chapter VII.5
Staph aureus : Chapter VIII.3
Staph aureus : Chapter X.11
Staph aureus : Chapter XIX.4
Staph aureus : Chapter XIX.5
Staph aureus food poisoning : Chapter IX.3
Staph epidermidis : Chapter VI.2
Staph epidermidis : Chapter VI.5
staph pneumonia : Chapter VI.11
staphylococcal scalded skin syndrome : Chapter VI.2
staphylococcal toxic shock : Chapter VI.18
staphylococci : Chapter VI.2
Staphylococcus epidermidis : Chapter XXI.2
statistics : Chapter XXII.1
status asthmaticus : Chapter VIII.2
status epilepticus : Chapter VI.15
status epilepticus : Chapter XIV.9
status epilepticus : Chapter XVIII.5
status epilepticus, refractory : Chapter XVIII.5
status epilepticus, simple : Chapter XVIII.5
steatorrhea : Chapter VIII.3
steatorrhea : Chapter IX.12
stem cell transplant : Chapter V.6
stem cell transplantation : Chapter XI.4
stem cell transplantation : Chapter XII.1
stereopsis : Chapter XVII.3
steroids : Chapter V.4
steroids : Chapter VIII.2
steroids : Chapter XX.2
Stevens Johnson syndrome : Chapter V.2
Stevens-Johnson syndrome : Chapter VI.5
Stevens-Johnson syndrome : Chapter VI.17
Stickler syndrome : Chapter IV.5
Stimson method of shoulder reduction : Chapter XIX.7
stimulants : Chapter I.10
stings : Chapter XIV.9
stirrup splint : Chapter XIX.2
stockinette : Chapter XIX.2
stomatitis : Chapter VI.9
stomatitis : Chapter XVI.1
stool Wright stain : Chapter IX.3
STORCH : Chapter III.11
strabismus : Chapter XII.3
strabismus : Chapter XVII.2
strabismus : Chapter XVII.3
straight blade : Chapter XIV.4
stratum corneum : Chapter XXI.6
strawberry hemangioma : Chapter XXI.3
streak gonad : Chapter XIII.11
Strep agalactiae : Chapter VI.2
Strep bovis : Chapter VI.2
Strep faecalis : Chapter VI.2
Strep pneumoniae : Chapter VI.2
Strep pneumoniae : Chapter VI.7
Strep pneumoniae : Chapter VI.11
Strep pneumoniae : Chapter VI.16
Strep pyogenes : Chapter VI.2
Strep pyogenes : Chapter VI.13
Strep pyogenes : Chapter VI.16
Strep pyogenes : Chapter VI.18
Strep pyogenes : Chapter VI.33
Strep pyogenes : Chapter VI.34
Strep viridans : Chapter VI.2
Strep viridans : Chapter VII.5
streptococcal pharyngitis : Chapter VI.9
streptococcal toxic shock : Chapter VI.18
streptococci : Chapter VI.2
Streptococcus mutans : Chapter I.12
streptomycin : Chapter VI.19
stridor : Chapter VI.12
stridor : Chapter VII.7
stridor : Chapter VIII.6
stridor : Chapter VIII.10
stridor : Chapter IX.6
stridor : Chapter IX.7
stridor : Chapter XIV.3
stridor : Chapter XIV.4
stroke volume : Chapter XIV.2
Strongyloides stercoralis (threadworm) : Chapter VI.31
study blinding : Chapter XXII.2
study blinding : Chapter XXII.3
Sturge-Weber disease : Chapter XVIII.12
Sturge-Weber syndrome : Chapter XVIII.19
Sturge-Weber syndrome : Chapter XXI.3
stuttering : Chapter I.9
subacute endocarditis : Chapter VII.5
subarachnoid hemorrhage : Chapter XVIII.13
subcutaneous emphysema : Chapter VI.10
subcutaneous emphysema : Chapter XIV.7
subcutaneous nodules : Chapter VII.4
subdural empyema : Chapter VI.7
subdural hematoma : Chapter XIV.12
subdural hematoma : Chapter XVIII.13
subglottic stenosis : Chapter VIII.10
subluxation : Chapter XIX.7
subluxed radial head : Chapter XIX.7
submersion injury : Chapter XIV.6
subperiosteal abscess : Chapter VI.8
subspecialty referral : Chapter I.1
substance abuse : Chapter XIV.12
substance abuse : Chapter XX.3
substance abuse : Chapter XX.4
sucking chest wound : Chapter XIV.7
sucrose : Chapter II.3
sudden infant death syndrome (SIDS) : Chapter III.1
sudden infant death syndrome (SIDS) : Chapter VIII.12
sugar tong splint : Chapter XIX.2
suicide : Chapter XX.4
suicide : Chapter XX.5
sulbactam : Chapter VI.2
sulbactam : Chapter VI.5
sulfasalazine : Chapter IX.11
sulfonamide : Chapter VI.5
supine sleeping : Chapter VIII.12
supraclavicular lymphadenopathy : Chapter VI.34
supracondylar fracture : Chapter XIX.1
supracondylar fracture : Chapter XIX.2
suprapubic aspiration : Chapter XIII.6
supraventricular tachycardia : Chapter VII.6
supraventricular tachycardia : Chapter XIV.1
surfactant : Chapter III.6
surfactant : Chapter VIII.4
sustained fever : Chapter VI.3
sutures : Chapter X.1
SVT : Chapter VII.6
SVT : Chapter XIV.1
sweat chloride test : Chapter VIII.3
sweat chloride test : Chapter VIII.5
Sydenham's chorea : Chapter VII.4
syncope : Chapter VII.6
syngeneic transplant : Chapter V.6
synovitis : Chapter XVI.2
syphilis : Chapter III.11
syphilis : Chapter VI.21
systemic inflammatory response syndrome : Chapter III.10
systemic inflammatory response syndrome : Chapter VI.16
systemic JRA : Chapter XVI.2
systemic lupus erythematosus (SLE) : Chapter XI.6
systemic lupus erythematosus (SLE) : Chapter XIII.1
systemic lupus erythematosus (SLE) : Chapter XVI.1
systemic vascular resistance : Chapter XIV.2
T3 : Chapter XV.2
T4 : Chapter XV.2
tabes dorsalis : Chapter VI.21
tachycardia : Chapter XIV.2
tactile temperature : Chapter VI.3
Taenia saginata : Chapter VI.31
Taenia solium : Chapter VI.31
Takayasu arteritis : Chapter XVI.3
tamponade : Chapter XIV.2
Tanner stage : Chapter XIX.3
Tanner stage : Chapter XX.1
Tanner's height prediction formula : Chapter I.2
tanning : Chapter XV.4
target sign : Chapter X.4
Tay-Sachs disease : Chapter IV.1
tazobactam : Chapter VI.5
telephone care : Chapter I.1
temperature regulation : Chapter VI.3
temporal lobe seizures : Chapter XVIII.4
tendonitis : Chapter XIX.8
tennis elbow : Chapter XIX.8
tension pneumothorax : Chapter XIV.7
teratogenesis : Chapter IV.2
terbinafine : Chapter VI.32
terbutaline : Chapter VIII.2
tertian malaria : Chapter VI.30
tertiary intention : Chapter X.1
tertiary syphilis : Chapter VI.21
testicular rupture : Chapter XIII.10
testicular torsion : Chapter XIII.10
testosterone : Chapter XIII.12
testosterone : Chapter XX.2
tetanus toxoid : Chapter I.4
tetanus toxoid : Chapter VI.2
tetany : Chapter XV.6
tetracaine : Chapter XVII.5
tetracycline : Chapter VI.5
tetracycline : Chapter XVII.1
tetracycline : Chapter XXI.2
tetrahydrocannabinoid : Chapter XX.3
tetralogy of Fallot : Chapter VII.3
thalassemia : Chapter IV.1
thalassemia : Chapter XI.1
thalassemia : Chapter XI.2
thelarche : Chapter XX.1
theophylline : Chapter VIII.2
theophylline : Chapter XIV.9
thermoregulation : Chapter III.5
thiamine : Chapter II.6
thiazide diuretics : Chapter VIII.4
thigh pain : Chapter XIX.6
thioglycolate : Chapter VI.2
third degree burns : Chapter XXI.4
third party payer : Chapter I.11
thoracentesis : Chapter XIV.7
thrombasthenia : Chapter XI.6
thrombocytopenia : Chapter XI.4
thrombocytopenia : Chapter XI.5
thrombocytopenia : Chapter XIII.5
thrombocytopenia : Chapter XVI.1
thrombocytopenia with absent radii (TAR) : Chapter XI.4
thrombocytosis : Chapter VI.17
thrombotic thrombocytopenic purpura (TTP) : Chapter XI.6
thrombotic thrombocytopenic purpura (TTP) : Chapter XIII.5
thrombus : Chapter VII.5
thrush : Chapter VI.32
thumb spica splint : Chapter XIX.2
thyroid : Chapter XV.2
thyroid cancer : Chapter XV.2
thyroid dysgenesis : Chapter XV.2
thyroid stimulating immunoglobulin : Chapter XV.2
thyroiditis : Chapter XV.2
thyroxin : Chapter XV.2
tibial tuberosity apophysitis : Chapter XIX.8
ticarcillin : Chapter VI.5
tick removal method : Chapter VI.26
tidal volume : Chapter XIV.5
time-out : Chapter I.6
time-out : Chapter I.7
tinea : Chapter VI.32
tinea capitis : Chapter VI.32
tinea corporis : Chapter VI.32
tinea cruris : Chapter VI.32
tinea pedis : Chapter VI.32
tinea unguium : Chapter VI.32
tinea versicolor : Chapter VI.32
tissue adhesive : Chapter X.1
TNF (tumor necrosis factor) : Chapter VI.16
tobacco : Chapter XX.3
tobramycin : Chapter VI.5
tocolytics : Chapter III.4
tocopherol : Chapter II.6
Todd paralysis : Chapter XVIII.4
togavirus : Chapter VI.1
toilet training : Chapter I.6
toll-like receptors : Chapter VI.16
tolnaftate : Chapter VI.32
Tonic neck response : Chapter XVIII.1
tonic-clonic seizure : Chapter XVIII.4
tonsillitis : Chapter VI.9
tooth avulsion : Chapter I.12
toothpaste : Chapter I.6
TORCH : Chapter III.11
TORCHS : Chapter III.11
torsades de pointes : Chapter VII.6
torus fracture : Chapter XIX.1
total anomalous pulmonary venous return : Chapter VII.3
total anomalous pulmonary venous return : Chapter VIII.8
total body water : Chapter II.4
total iron binding capacity (TIBC) : Chapter XIV.11
toxic shock syndrome : Chapter VI.2
toxic shock syndrome : Chapter VI.18
toxic synovitis : Chapter XIX.5
toxicology : Chapter XIV.9
toxidrome : Chapter XIV.9
toxin : Chapter VI.18
toxoid : Chapter I.4
toxoid : Chapter VI.2
toxoplasmosis : Chapter III.11
toxoplasmosis : Chapter VI.31
tracheal aspirate : Chapter III.10
tracheal aspirate : Chapter VI.11
tracheal foreign body : Chapter VIII.6
tracheal intubation : Chapter XIV.1
tracheal intubation : Chapter XIV.4
tracheal tube : Chapter XIV.1
tracheal tube : Chapter XIV.4
tracheitis : Chapter VI.12
tracheoesophageal fistula : Chapter X.9
tracheomalacia : Chapter VII.7
tracheomalacia : Chapter VIII.10
tracheostomy : Chapter VIII.10
tracheostomy : Chapter XIV.3
trachoma : Chapter VI.21
trachoma : Chapter XVII.4
traction apophysitis : Chapter XIX.8
transfusion : Chapter XI.3
transfusion : Chapter XIV.2
transfusion : Chapter XIV.8
transient erythroblastopenia of childhood : Chapter XI.4
transient erythroblastopenia of childhood (TEC) : Chapter XI.1
transient evoked otoacoustic emissions (TEOAE) : Chapter I.5
transient hypogammaglobulinemia of infancy : Chapter V.5
transient synovitis : Chapter XIX.5
transient synovitis : Chapter XIX.6
transient tachypnea of the newborn : Chapter III.6
transition : Chapter III.1
transition zone : Chapter IX.9
translocation : Chapter IV.7
transmucosal inflammation : Chapter IX.11
transposition of the great vessels : Chapter VII.3
transurethral catheterization : Chapter XIII.6
trauma : Chapter XIV.8
traumatic chest wound : Chapter XIV.7
Treacher Collins syndrome : Chapter X.10
tree nut allergy : Chapter V.3
trematodes (flukes) : Chapter VI.31
Treponema pallidum : Chapter VI.21
tretinoin : Chapter XXI.2
triamcinolone : Chapter VIII.2
triamcinolone : Chapter XXI.1
triceps reflex : Chapter XVIII.1
trichobezoar : Chapter IX.7
Trichomonas vaginalis : Chapter VI.21
Trichomonas vaginalis : Chapter VI.31
Trichophyton : Chapter VI.32
Trichuris trichiura (whipworm) : Chapter VI.31
tricuspid atresia : Chapter VII.3
tricuspid insufficiency : Chapter VII.2
tricuspid stenosis : Chapter VII.2
tricyclic antidepressants : Chapter XIV.9
trigeminal nerve (CN V) : Chapter XVIII.1
trimethoprim-sulfamethoxazole : Chapter VI.5
triple screen : Chapter IV.1
trisomy 13 : Chapter IV.3
trisomy 18 : Chapter IV.1
trisomy 18 : Chapter IV.3
trisomy 21 : Chapter I.2
trisomy 21 : Chapter IV.1
trisomy 21 : Chapter IV.3
trochlear nerve (CN IV) : Chapter XVIII.1
trophozoite : Chapter VI.30
tropical pyomyositis : Chapter X.11
tropical sprue : Chapter IX.12
Trousseau sign : Chapter XV.6
truncus arteriosus : Chapter VII.3
Trypanosoma brucei gambiense : Chapter VI.31
Trypanosoma brucei rhodesiense : Chapter VI.31
Trypanosoma cruzi : Chapter VI.31
Trypanosomiasis : Chapter VI.31
TSH : Chapter XV.2
TSS : Chapter VI.18
T-test : Chapter XXII.1
TTN : Chapter III.6
TTP : Chapter XIII.5
tube thoracostomy : Chapter XIV.7
tuberculosis : Chapter VI.19
tuberculosis : Chapter VI.34
tuberculosis : Chapter XV.4
tuberin : Chapter XVIII.12
tuberous sclerosis : Chapter XVIII.11
tuberous sclerosis : Chapter XVIII.12
tubo-ovarian abscess : Chapter VI.21
tumor : Chapter XII.3
tumor : Chapter XXI.6
tumor lysis : Chapter XII.1
tumor lysis : Chapter XII.2
tumor necrosis factor (TNF) alpha : Chapter VI.3
tunica albuginea : Chapter XIII.10
Turner syndrome : Chapter I.2
Turner syndrome : Chapter IV.3
Turner syndrome : Chapter XIII.11
Turner syndrome : Chapter XV.3
Turner syndrome : Chapter XX.1
twinning (of teeth) : Chapter I.12
twins : Chapter III.4
tympanic thermometry : Chapter VI.3
tympanocentesis : Chapter VI.6
tympanogram : Chapter I.5
tympanostomy tubes : Chapter VI.6
type 1 diabetes : Chapter XV.1
type 2 diabetes : Chapter XV.1
type and crossmatch : Chapter XI.7
type and hold : Chapter XI.7
type and screen : Chapter XI.7
typhoid fever : Chapter IX.3
typhus : Chapter VI.2
tyramine : Chapter V.3
tyrosinemia : Chapter IX.5
Tzanck smear : Chapter XXI.6
ulcerative colitis : Chapter IX.11
ulcers : Chapter XXI.6
ulnar gutter splint : Chapter XIX.2
ultrasound, fetal : Chapter IV.1
ultrasound, prenatal : Chapter IV.1
ultrasound, prenatal : Chapter X.6
ultrasound, prenatal : Chapter X.7
ultraviolet light : Chapter XVII.5
umbilical artery catheter : Chapter III.8
umbilical vein catheterization : Chapter III.3
unconjugated bilirubin : Chapter III.2
unconjugated estriol : Chapter IV.1
undecylenic acid : Chapter VI.32
ungual fibroma : Chapter XVIII.12
upper airway obstruction : Chapter XIV.3
upper GI bleeding : Chapter IX.10
urea cycle : Chapter IV.4
uremia : Chapter XIII.4
uremia : Chapter XIII.5
ureteral colic : Chapter IX.2
ureterocele : Chapter XIII.7
ureteropelvic junction (UPJ) obstruction : Chapter XIII.7
urethral catheterization : Chapter XIII.6
urethral prolapse : Chapter XIII.7
urethritis : Chapter VI.17
URI : Chapter VI.9
uridine diphosphate glucuronyltransferase (UDPGT) : Chapter III.2
urinalysis : Chapter III.10
urinary continence : Chapter XIII.9
urinary human chorionic gonadotropin-core : Chapter IV.1
urinary tract infection : Chapter VI.2
urinary tract infection : Chapter VI.3
urinary tract infection : Chapter XIII.6
urine culture : Chapter III.10
urticaria : Chapter V.2
urticaria : Chapter V.3
urticarial vasculitis : Chapter XVI.3
UTI : Chapter VI.2
UTI : Chapter XIII.6
uveitis : Chapter IX.11
uvulitis : Chapter VI.9
vaccination : Chapter VI.1
vaccine associated paralytic polio : Chapter VI.24
vaccinia : Chapter VI.1
vaccinia : Chapter VI.15
VACTER association : Chapter IV.2
VACTER association : Chapter X.9
vacuum-assisted delivery : Chapter III.3
vagal maneuver : Chapter VII.6
vaginal candidiasis : Chapter VI.32
vaginitis : Chapter XX.7
vagus nerve (CN X) : Chapter XVIII.1
valacyclovir : Chapter VI.21
valproic acid : Chapter XVIII.4
valproic acid : Chapter XVIII.5
Valsalva : Chapter VII.6
valvular insufficiency : Chapter VII.1
valvulitis : Chapter VII.4
valvulitis : Chapter VII.5
vancomycin : Chapter VI.2
vancomycin : Chapter VI.5
vancomycin : Chapter VI.16
vancomycin : Chapter XIX.4
variance : Chapter XXII.1
varicella : Chapter VI.1
varicella : Chapter VI.22
varicella : Chapter XVIII.17
varicella : Chapter XXI.6
varicella vaccine : Chapter I.4
varicella-zoster virus : Chapter VI.1
varicella-zoster virus : Chapter VI.15
varices : Chapter IX.10
varicocele : Chapter X.2
variola : Chapter VI.1
vascular malformation : Chapter XXI.3
vascular ring : Chapter VII.7
vascular ring : Chapter VIII.10
vascular sling : Chapter VII.7
vasculitis : Chapter VI.17
vasculitis : Chapter XIII.1
vasculitis : Chapter XVI.1
vasculitis : Chapter XVI.2
vasculitis : Chapter XVI.3
vasoconstriction : Chapter XIV.2
vaso-occlusive crisis : Chapter XI.3
VATER association : Chapter IV.2
VDRL : Chapter VI.21
VDRL : Chapter XVI.1
vector : Chapter VI.15
vector : Chapter VI.31
vein of Galen : Chapter XVIII.19
venous blood gas : Chapter VIII.1
venous congestion : Chapter VII.1
ventilation : Chapter VIII.1
ventilator : Chapter XIV.3
ventilator : Chapter XIV.5
ventilator rate : Chapter XIV.5
ventricular fibrillation : Chapter XIV.1
ventricular septal defect : Chapter VII.2
ventricular tachycardia : Chapter VII.6
ventricular tachycardia : Chapter XIV.1
ventriculoperitoneal shunt : Chapter VI.2
ventriculoperitoneal shunt : Chapter XVIII.9
verotoxin : Chapter IX.3
verotoxin : Chapter XIII.5
vesicle : Chapter XXI.6
vesicoureteral reflux : Chapter XIII.6
vesicoureteral reflux : Chapter XIII.7
vigabatrin : Chapter XVIII.12
vinca alkaloids : Chapter XII.1
violence : Chapter XX.4
viral conjunctivitis : Chapter XVII.4
viral croup : Chapter VI.12
viral meningitis : Chapter VI.14
viral myositis : Chapter XVIII.15
virilization : Chapter XV.4
virology : Chapter VI.1
virus : Chapter VI.1
visual evoked response : Chapter XVIII.8
visual reinforcement audiometry (VRA) : Chapter I.5
vital signs : Chapter XIV.8
vital signs : Chapter XIV.9
vitamin A : Chapter II.6
vitamin A : Chapter VIII.4
vitamin B1 : Chapter II.6
vitamin B12 : Chapter II.6
vitamin B2 : Chapter II.6
vitamin B6 : Chapter II.6
vitamin C : Chapter II.6
vitamin D : Chapter II.6
vitamin D : Chapter XIII.4
vitamin D : Chapter XV.6
vitamin D dependent rickets : Chapter XV.6
vitamin deficiency : Chapter II.6
vitamin E : Chapter II.6
vitamin K : Chapter II.6
vitamin K : Chapter III.1
vitamin K deficiency : Chapter XI.6
vitamins : Chapter XIV.9
vitelline duct : Chapter IX.13
vitreous humor : Chapter XVII.2
vocal chord paralysis : Chapter VIII.10
volar forearm splint : Chapter XIX.2
volar wrist splint : Chapter XIX.2
volume ventilation : Chapter XIV.5
volvulus : Chapter IX.2
volvulus : Chapter IX.10
volvulus : Chapter IX.13
volvulus : Chapter X.5
vomiting : Chapter II.4
vomiting : Chapter IX.3
vomiting : Chapter IX.6
vomiting : Chapter X.8
von Hippel-Lindau disease : Chapter XVIII.12
von Recklinghausen disease : Chapter XVIII.11
von Willebrand disease : Chapter XI.6
VSD : Chapter VII.1
VSD : Chapter VII.2
VZIG : Chapter XXI.6
VZV : Chapter VI.1
WAGR : Chapter XII.3
Waldeyer ring : Chapter VI.9
warfarin : Chapter XI.6
warts : Chapter VI.1
warts : Chapter XXI.6
water heater temperature reduction : Chapter I.6
water safety : Chapter I.6
weaning : Chapter I.6
Webril : Chapter XIX.2
Wegener's granulomatosis : Chapter VIII.7
Wegener's granulomatosis : Chapter XVI.3
Weil's syndrome : Chapter VI.28
welding : Chapter XVII.5
western black-legged tick : Chapter VI.27
western blot : Chapter VI.20
western encephalitis : Chapter VI.15
western equine encephalitis : Chapter VI.1
wet drowning : Chapter XIV.6
wheal : Chapter XXI.6
wheat allergy : Chapter V.3
wheezing : Chapter VIII.2
wheezing : Chapter VIII.4
wheezing : Chapter VIII.6
whey : Chapter II.2
whey : Chapter II.3
whey : Chapter V.3
whitehead : Chapter XXI.2
whole blood : Chapter XIV.8
whole bowel irrigation : Chapter XIV.9
whole bowel irrigation (WBI) : Chapter XIV.11
whooping cough : Chapter VI.10
Wilms tumor : Chapter XII.3
Wilson disease : Chapter IX.5
Wiskott-Aldrich syndrome : Chapter V.5
Wiskott-Aldrich syndrome : Chapter XXI.1
Wolff Parkinson White (WPW) syndrome : Chapter VII.6
Wolffian duct : Chapter XIII.11
wood tick : Chapter VI.26
Wood's light : Chapter XVII.5
wound botulism : Chapter XVIII.6
wound healing : Chapter X.1
wound management : Chapter X.1
Wucheria bancrofti : Chapter VI.31
xerophthalmia : Chapter II.6
xerosis : Chapter XXI.1
X-linked : Chapter IV.7
X-linked agammaglobulinemia (XLA) : Chapter V.5
X-linked recessive : Chapter IV.4
XXY syndrome : Chapter IV.3
XYY syndrome : Chapter IV.3
yaws : Chapter VI.21
yellow fever : Chapter VI.15
yellow fever virus : Chapter VI.1
zafirlukast : Chapter VIII.2
zileuton : Chapter VIII.2
zinc pyrithione : Chapter VI.32
zinc sulfide : Chapter VI.32
zinc undecylenate : Chapter VI.32
zoster : Chapter VI.1
zoster : Chapter VI.22
zoster : Chapter XXI.6


Return to Table of Contents

University of Hawaii Department of Pediatrics Home Page